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Abstract 
 
Heritable variation is important in disease progression, therefore its association 
with HIV/AIDS was analyzed. APOBEC3G is a unique cellular gene that 
influences HIV infectivity. It belongs to family of cytidine deaminases and is both 
an RNA and DNA editing enzyme. APOBEC3G is a good candidate for HIV 
restriction because it allows the expression of an antiviral phenotype in non-
permissive cells consequently this innate immune defense may provide the basis 
for the design of new therapies for HIV. Variation in the upstream non-coding 
region of APOBEC3G was studied. Six base variants were found at positions -90, 
-163, -166, -571, -590 and -821. In addition, promoter analysis identified 
promoters in the upstream non-coding region. Indirect genotyping assays were 
developed to genotype the participants at -571 and H186R. The frequency of -571 
GG was 70 %. The frequency of the TT genotype of H186R was 20 %. The GG 
genotype was selected against in the HIV + group of the study participants. This is 
indicative that this SNP has disease modifying effects. The TT genotype was 
related to increased progression to AIDS confirming the results of previous 
studies. 
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1. HIV/AIDS 
 
Universal statistics reveal that Sub-Saharan Africa has the highest HIV/AIDS 
infections. In Sub-Saharan Africa there are 22.5 million adults living with HIV 
and approximately 1.7 million adults and children had become infected with the 
virus in 2007.These alarming statistics are cause for concern especially since 
Southern Africa accounts for one third of all new HIV infection and AIDS deaths 
globally. South Africa is the hardest hit country with largest number of people 
infected and has the highest HIV prevalence of any country. The virus is 
spreading throughout the population and is not limited to high risk populations 
such as sex-workers (UNAIDS/WHO, 2005). The key to curbing the spread of the 
virus is to implement efficient and practical strategies to help those infected with 
and affected by HIV/AIDS. 
 
2. History of HIV 
 
2.1. From SIV to HIV  
 
The explosion of HIV-1 infection in humans can be traced to the origins of the 
ancestral virus. HIV originated from the zoonotic transfer of SIV from non human 
primates. Molecular evidence is consistent with this transfer having occurred in 
Cameroon. SIV was previously only identified in captive chimpanzees (Pan 
troglodytes troglodytes) (Keele et al, 2006). The ability to detect this virus in wild 
living chimps and use these viral sequences in phylogenetic analysis, allows for 
the expectation of whether SIV is indeed the origin of HIV-1 infection. 
 
Chimpanzees are native to Cameroon, which is located north of the DRC (Keele 
et al, 2006). Two subspecies of chimps inhabit this region and are geographically  
isolated by the Sanaga River. P.t vellerosus inhabits north of the river while the 
P.t.traglodytes is found south of the river much closer to the DRC (Keele et al,  
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2006). Different regional sites were sampled in the southern region of Cameroon. 
HIV-1 proteins such as gag, pol, and env were detected in the samples. The Pol 
and gp41 sequences from wild living chimps showed that HIV-1 group M subtype 
clusters identified new strains that were sequenced (Keele et al, 2006). 
Interestingly the HIV-1 M/A is most closely related to the samples from the 
region bordering the DRC. HIV-1 N clusters more close to the samples from 
further north of the border, between Cameroon and the DRC.  
 
This clustering is indicative of an ancestral virus, most likely SIV, which infected 
an individual/s who then migrated into the DRC, specifically Leopoldville 
(Kinshasa), as it was the metropolis of the early twentieth century where the HIV-
1 epidemic has its origins. However, the origin of SIVcpz itself remains elusive. 
SIVs occur in 26 nonhuman primate species (Keele et al, 2006). They do not, 
however, cause disease in the natural hosts, but form a natural reservoir of the 
virus (Hahn et al, 2000). This is confirmed by the taking a closer look at the viral 
lineages. The divergence of several clusters was most likely caused by the 
evolution of the host lineage because SIV form distinct host specific clusters 
within the phylogenetic tree (Hahn et al, 2000). SIV cpz as mentioned earlier is 
found in wild P.t.troglydytes endemic in central Africa and these viruses form a 
monophyletic clade distinct from any other lentiviruses. Thus again confirming 
another example of host-dependant viral evolution (Hahn et al, 2000). Sequence 
analysis has helped clarify zoonotic transmission of SIVs to humans. It is 
estimated that there have been no fewer than 7 independent cross species 
transmission to humans giving rise to HIV-1 groups (Hahn et al 2000).The 
characterization of SIVcpz across the gag, pol and env regions has shown that this  
virus is clearly a recombinant virus. This is so because the SIV cpz is not 
particularly closely related to any one human or chimp virus. The phylogenetic 
analysis revealed a single breakpoint in the tree when looking at Env and pol 
proteins. SIVcpz Pol sequences clustered more closely with SIVrcm (SIV from 
Red Capped Mangabeys) during the phylogeny. SIV cpz Env sequences clustered  
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more closely with SIVgsn (Greater Spot-nosed monkeys) sequences than any 
other SIV lineages. This is direct evidence that the hybrid SIVcpz has a more 
recent transmission to humans. Therefore by extrapolation it can be argued that 
SIVs from monkeys can also have been transmitted to humans and may also 
allude to the origins of HIV-1. Human exposure to SIVs is mostly likely through 
contact with animal blood either through consumption of bush meat or through 
biting and of predation of wild living species (Worobey et al, 2008). The only 
plausible explanation for the spread of SIVs to humans and subsequent evolution 
of HIV is that SIVs must have had to undergo some changes to adapt to the host 
in addition to taking advantage of the socio-behavioural factors that were rife in 
Africa at the time (Gao et al, 1999). 
  
2.2 HIV in humans 
HIV-1 group M accounts for more than 95 % of all HIV infection around the 
world save for HIV-2 infections in certain parts of Africa (Lemey et al, 2003). 
Group M is composed of numerous different subtypes, each endemic in certain 
parts of the world, e.g. subtype B is found mainly in Europe, the Americas, Japan 
and Australia (Heeney et al, 2006). In southern Africa, subtype C is the most 
common. (Lemey et al, 2003).  
DNA sequencing of archival samples from Zaire (now the DRC) was used to date 
the origin of HIV -1 and to discern its evolutionary history (Worobey et al, 2008). 
 The archival samples are designated ZR 59 (a blood plasma sample from 1959)  
and DRC60 (biopsy specimen from female patient). The phylogenetic analysis 
showed that these sequences shared a common ancestor at least 50 years ago 
because of the short nodal distance between the two (Worobey et al, 2008). 
Particularly the DRC60 sequence was found to cluster close to the A subtype 
ancestral node in the phylogenetic tree while the ZR59 sequence clustered closer 
to the subtype D (Worobey et al, 2008). This indicates that even 50yrs ago group 
M strains had evolved into distinct subtypes that were circulating within the  
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populations of this region (Worobey et al, 2008). The phylogenetic analysis 
indicates too that there is substantial genetic diversity between the two ancestral 
sequences. This further confirms that the virus was present long before the 
epidemic was characterized.  
 
Urbanization seems to have played a vital role in the exponential rise of the 
disease in Africa because the two ancestral sequences cluster with other strains 
from the same region rather then the same subtype, giving rise to viral lineages 
which are more diverse within viral subtypes. Thus it was concluded that the 
diversification of HIV-1 group M viruses began in Kinshasa (Keele et al, 2006).  
 
Like HIV-1 the causative agent of HIV-2 is known to be SIVsm (SIV from Sooty 
Mangabey). The Sooty Mangabeys naturally inhabit the forest of Senegal east to 
Ghana. The origin of HIV-2 has not been so contenscious. A natural reservoir of 
the virus was detected in these monkeys as early as 1989 (Hirsch et al, 1989). 
Unlike HIV-1, each HIV-2 subtype was a result of cross-species transmission. 
The most recent common ancestor of HIV-2 subtype A was dated to be ~1940 and 
subtype B 1945 in Guinea-Bissau (Lemey et al, 2003). Subtypes A and B are 
linked to the epidemic in this region while other subtypes have been identified in 
singly infected people. Like HIV-1 transmission of the virus as been marked by a 
period of untracability followed by an exponential rise in infections. This rise of  
infections is estimated to occur around the same time as the War of Independence 
between 1963 and 1974 (Lemey et al, 2003). Once again it is evident that viral 
epidemics are reliant on socio-economic conditions. 
 
3. HIV Life Cycle 
 
HIV-1 has a high mutation rate of 3 x 10
-5 
per nucleotide base per replication 
cycle (Sharp, 2002). Because of this high mutation rate the virus evolves rapidly.  
This is challenging because this generates masses of sequence change per decade  
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of the pandemic. Nonetheless, the viral sequence analysis is what is producing the 
most important information on the origins of HIV-1 and its co-evolution with 
humans. 
 
The HIV infection begins with HIV attaching to the CD4 cell via the gp120 
molecules exposed on the surface of the virion. This binding induces a 
conformational change in gp 120 allowing it to bind to CCR5 (Doms and Trono, 
2000). The conformational change allows gp41 which becomes exposed to initiate 
fusion of the viral and host membranes. The virus then releases its capsid (which 
contains the two RNA strands) into the cellular compartment of the host cell. 
Once in the host cell there is a partial uncoating of the capsid to expose the RNA 
strands (Doms and Trono, 2000). The viral reverse transcriptase converts the 
RNA to DNA as this is a much more stable molecule in the cell. The DNA then 
enter in host nucleus where together with viral intergrase is spliced into the host 
genome (Doms and Trono, 2000). Once it is integrated into the host genome it is 
called a provirus. This provirus can remain dormant and can become active at any 
stage. If the provirus is active it will generate viral proteins for new virions. It 
uses the host cells own enzymes to transcribe the double stranded DNA to mRNA. 
Once the mRNA is processed in the nucleus, it is transported to the cytoplasm  
where the viruses once again hi-jacks the host protein making processes to 
produce the viral proteins such as env(gp 160), gag, gag-pol, vif vpr, vpu, rev, tat 
and nef (Doms and Trono, 2000). The initial env protein is processed in the ER 
and Golgi into the gp120 and gp41. The gp 120 is glycosylated .The gag and gag-
pol polyproteins aggregate near the membrane and interact with plasma 
membrane and the gp 41 present in the membrane (Doms and Trono, 2000). As 
the gag and gag-pol aggregate at the plasma membrane the virion begins to 
assemble. Subsequently the new virions are extruded from the host cell 
membrane. As budding occurs the virion takes the host cell lipid layer in which 
the env protein is bound. The virion then undergoes maturation. A virally-encoded 
proteinase enzyme cleaves the precursor gag, gag-pol into functional proteins. 
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Figure 1. Overview of HIV replication detailing the steps of HIV infection. 
 
4. Identification of host genes important in HIV 
 
The HIV genome is composed of nine genes which encode 3 structural proteins 
(gag, pol, env), 2 regulatory proteins (tat, rev) and four accessory proteins (nef, 
vif, vpu, vpr) (Doms and Trono, 2000). It is important to understand how natural 
selection has had an impact on the HIV and SIV genomes because genome 
variation undoubtedly has profound effects on the virus as well as the host. SIVs 
do not cause disease in their natural hosts probably because this virus and the host 
have reached equilibrium because of the long occurrence of the virus in chimps 
and monkeys (Bailes et al, 2008). It is reasonable to assume that the SIV genes 
would have to adapt to their host environment in order for the virus to become 
transmissible. Examination of the HIV-1 and HIV-2 groups reveals subtypes with 
differing rates of transmission in different populations. In addition some subtypes 
are mosaics of two distinct subgroups e.g. Subtype A + CRF02_AG accounts for a 
large proportion of new infections worldwide. This viral heterogeneity is also  
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common in SIVs indicated by SIVcpz which is a hybrid of SIVrcm and SIVgsn 
(Bailes et al, 2008). This enforces that the viruses have had to adapt to their 
changing environments in order to ensure transmissibility.  
 
There are many approaches that have been used to identify host proteins important 
in HIV. Classical analysis of host genetics and its involvement in viral genetics 
was studied with candidate gene studies. Numerous AIDS restriction genes that 
effect susceptibility to viral infection have been discovered via this approach 
(Hutcheson et al, 2007). Candidate gene approaches are hypothesis based. A 
candidate gene is studied for association in order to ascertain any frequency 
differences between the case and control. The advantage of this method is that the 
study population need not be large. It is often better to have a larger study 
population to ensure accuracy of predictions. The disadvantage of this method  
lies with the fact that the investigator must have some knowledge about the 
candidate gene or the study could be uninformative and a waste. Most candidate 
gene studies have focused on European populations (or populations of European 
origin); little information is available for the effects of variation in these genes in 
Sub-Saharan blacks where the epidemic is flourishing at an alarming rate. 
Nonetheless, a lot of population studies have focussed on African Americans. 
This does not give us a complete picture of the disease in Sub-Saharans Africa but 
is a good platform from which to grow. 
 
Chemokine receptors and their variants (CCR5), chemokine receptor ligands 
(SDF), cytokines (IL), the HLA system and various factors involved in cellular 
immunity such as TRIM5α, APOBEC3G and 3F have all been discovered by 
candidate gene approaches. 
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5. Candidate genes for HIV 
5.1. CCR5  
 
The most widely characterized cell surface molecule is CCR5, a chemokine  
receptor (Carrington et al, 2001). Chemokines are secreted from cells in response 
to an inflammatory reaction. This attracts white blood cells to the site of 
inflammation. Chemokines CCL 5, CCL3, CCL4, formerly called RANTES, MIP 
1α and MIP 1β, bind to chemokine receptors.  
 
Co-receptor selectivity in HIV-1 is dependant on the V3 loop of HIV. A portion 
of the V3 loop has a remarkably similar structure to the CXC and CC chemokines 
(natural ligands for CXCR4 and CCR5, respectively) β2-β3 hairpin loop (Cardozo 
et al, 2007). Functional role of V1/V2 region of HIV-1 in infection showed that 
the V3 loop is necessary for viral tropism, although the exact mechanism of action  
was not known (Koito et al, 1994). Modelling of the V3 loop showed the 
importance of three amino acids; 11, 24, 25 in determining this viral tropism. 
When these three amino acid residues have a positive charge then the virus will 
bind using CXCR4. The converse is true for negatively charged amino acid 
residues (Cardozo et al, 2007). In addition V3 loop like V1/V2 region protects the 
env from being targeted by neutralizing antibodies present in the host sera. 
Truncation of this loop confirms that HIV will adapt their use of CCR5 for their 
propagation (Laakso et al, 2007). This interesting feature gives insight into the 
mechanisms of drug resistance that HIV has and the novel manner it will interact 
with the cell surface to ensure its propagation. The mutations discussed above are 
in specific reference to HIV and how its mutations can alter the use of chemokines 
receptors which undoubtedly has an effect on viral propagation.  
 
The CCR5 co-receptor is a seven-transmembrane–spanning G-protein coupled 
receptor. The deletion allele of CCR5 has a 32 base pair deletion within the 
coding region. This leads to a frame shift mutation that introduces a stop codon in  
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the reading frame. As a result, a non-functional, truncated protein is produced 
(Alkhatib et al, 1996 & Carrington et al, 2001). Thus, there is no CCR5 on the cell 
surface. People homozygous for the mutation are resistant to initial infection by 
viruses utilizing CCR5 (Samson et al, 1996). However, CCR5 ∆32 homozygotes 
the viruses use CXCR4 co-receptor (Clapham & McKnight, 2001). 
Heterozygotes, however, are not resistant to infection but rate of progression to 
AIDS is delayed.  
 
The CCR5 deletion is found at a high frequency in northern Europe, a lower 
frequency in southern Europe and is non-existent in Africans. The CCR5 deletion 
is remarkable in that it may be a good example of a locus under adaptive 
evolution. The locus may have become preferentially selected to protect  
individuals where there are other illnesses endemic in that region (Stephens et al, 
1998). There is conflicting evidence for this positive selection. Some evidence is 
consistent with CCR5 del32 having been selected in human populations. Other 
evidence indicates that it could have become common by random population 
processes. Examination of frequencies of the CCR5 deletion in samples from the 
Bronze Age as compared with modern samples and 14
th
 century samples 
confirmed that this deletion was present long before it was selected as a 
preventative haplotype for plague or smallpox (Hedrick & Verrelli, 2006). But if 
the CCR 5 deletion is under positive selection then the linked variants around the 
CCR5 locus will have a reduced heterozygousity and high LD as the variant 
becomes common in the population. However, this is not the case for the CCR5 
locus. The LD for the SNPs around this locus was the same across the European, 
Asian and African populations (Sabeti et al, 2005). Extensive genetic analysis 
confirms that indeed this locus is under neutral evolution because deletion was not 
a significant in terms of the Fst among all the study populations. This confusion 
arose because there has been a steady increase in the frequency of the deletion in 
European populations across Europe (Novembre et al, 2005).  
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Indeed recent studies have shown the earlier methods used for detection of 
hotspots for positive selection may be flawed. Hotspots which have been 
evolutionary accelerated may be a result of GC-biased gene conversion (gBGC) 
and not signatures of positive selection after all (Berglund et al, 2009). Hotspots 
in the human genome are detected as candidates for positive selection but a bias is 
observed in the genes within the hotspots. The bias is such that there is consistent 
change of AT to GC (Galtier et al, 2009). This bias was observed in all regions of 
the genes and in non human primates too. Thus positive selection cannot be 
inferred unless gBGC can also be rejected as the cause of these signatures in 
human genes. 
 
5.2. The HLA system 
 
The HLA gene system is another gene discovered via the candidate gene 
approach. The HSA locus on chromosome 8 was important in susceptibility to 
HIV. The allele A of this marker SNP had a higher association to susceptibility of 
HIV in addition in HIV positive people the allele is associated with higher viral 
load and faster progression to AIDS (Loeuillet et al, 2008). The HIV viral load of 
an individual determines how long individuals will progress to AIDS (Fellay et al, 
2007). A GWS identified variants accountable for the difference in viral load 
between individuals (Fellay et al, 2007). The association study showed that 
polymorphisms in HLA loci were the major determinant for viral load variation 
(Fellay et al, 2007). The polymorphism of in the HLA complex P5 accounts for 
9.6 % of viral load variation in the GWS. This polymorphism is in high Linkage 
Disequilibrium with HLA-B * 57 polymorphism which to be overly expressed in 
infected individuals with low viral loads. Other studies show HIV mutations that 
allow the virus to escapes cytotoxic T lymphocyte killing are linked to certain 
HLA alleles in the population. This immune escape shapes viral evolution through 
imprinting of a specific HLA genotype. The presence of other escape mutants in 
other studies too, such as HLA-B *57 and HLA-B*51 (in the RT codon) confirms  
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that the active CTL epitopes will not disappear completely from a population 
(Brumme et al, 2007). Virologic escape is possible from HIV-1 infected 
individuals who possess HLA-B * 57 mutation (Bailey et al, 2007). Nonetheless, 
this may not explain virologic suppression in these individuals because escape 
mutants are known to have low viral fitness and thus may also lead to decreased 
viral load. In this specific case this patient had a mutation in gag epitopes of the 
CD +8 cells, drug resistant mutations ( M184V & T215Y) in reverse transcriptase 
and polymorphism in VPU gene which is responsible for the release of virions 
from an infected cell (Bailey et al,2007). When these mutations were present the  
patient had a higher viral load. Reversion of the mutations to the consensus 
sequence did not increase viral fitness either. Although it has not been shown 
implicitly, the reversion is more likely the cause of the virologic escape of the 
patient and thus the consequence of the patient‟s long-term survival. HLA-B 27 is 
another escape mutant that has been associated with long term non-progression in 
infected individuals. It is hypothesized that its activity is due to the presentation of 
a conserved Gag epitope on its surface (Brumme et al, 2007). These active CTL 
epitopes intensify the diversity of the circulating viral strains in a population. 
HLA alleles associated with delayed progression to Aids shows that they have a 
preference for HIV-1 p24 Gag protein.  
 
 6. siRNA technology 
 
Technology is rapidly advancing thus providing much stronger and novel ways to 
detect the involvement of genes in disease. One such technique is the use of gene 
knockdowns to discover the gene function in an attempt to change disease 
genotypes and ultimately control disease phenotypes. Viral proteins are dependant 
on the use of the host machinery to ensure fully functional virions are produced 
and go on to continue the infection. Host proteins that play a role in HIV infection 
were detected by using small interfering RNA (siRNA) molecules (Brass et al, 
2008). RNA molecules able to regulate gene expression are known as RNA  
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interfering molecules. RNA molecules which regulate gene expression fall into 
two categories; long ds RNA and small hairpins (Fire et al, 1998). The siRNA are 
generated from dsRNA which may be viral in origin or can be artificially 
introduced into the cell (Kanzaki et al, 2008). Micro RNA (miRNA) on the other 
hand is generated from within the cell from the cleaving of short hairpin 
structures. siRNA will induce the specific knockdown of the gene of interest and 
to facilitate this, the sequence of the gene of interest must be known for the  
siRNA to pair with the gene and induce the knockdown (Kanzaki et al, 2008). The 
earliest known involvement of RNAi in HIV pathogenesis described latency 
which is a very important contributing factor to the success of antiviral therapy. 
HIV -1 encodes its own siRNA. In addition to this it also encodes a suppressor 
protein tat which blocks the action of Dicer (RNA processing enzyme) (Bennasser 
et al, 2005). siRNA act on reverse transcription by degrading RNA transcribed 
from the proviral DNA (Gao et al, 2008). This degradation is only effective before 
the newly synthesized RNA is encapsidated. This encapsidation has evolved to 
protect degradation of the RNA. In addition to this HIV-1 may have evolved an 
added escape mechanism during its evolution to the host. The complementarity 
between the siRNA and its target must be perfect. HIV-1 averts the 
complementarity by the introduction of mutations, which may alter target 
sequence thereby reducing the efficacy of this approach (Kanzaki et al, 2008). 
Despite this RNAi therapy provides a novel way of reducing infection. Targeting 
highly conserved HIV-1 genes may be an interesting target for siRNA because the 
mutation rates may be lowered. 
 
7. Genome Wide Association studies for the detection of HIV genes 
 
Genome Wide Screens are increasing in popularity for the detection of genes 
involved in complex diseases such as HIV. Genome wide screens or association 
studies are particularly useful because they permit the examination of the entire 
genome across many unrelated individuals without any knowledge of any gene  
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functions or associations (Loeuillet et al, 2008). Direct genome wide association 
studies detect an increased number of particular functional variant in affected and 
unaffected individuals (Pearson & Manolio, 2008). Indirect genome wide 
association relies on Linkage Disequilibrium. Genome Wide studies are important 
in determining disease pathogenesis, which will ultimately lead to the production  
of effective therapies. They are advantageous for the identification of genes that 
exert small effects. These small cumulative effects are thought to underlie 
complex diseases (Lazarus et al, 2002). This approach has significant advantages 
over other approaches such as candidate gene studies. No prior knowledge 
regarding the gene function of the variants is required thus no assumptions are 
necessary regarding the type of variant involved (Hutcheson et al, 2007). In 
addition to this the GWS are particularly useful as the variants do not need to be 
localized within a genomic region. Advances such as low cost of genotyping a 
large variety of SNPs in a large population makes this ideal for high throughput 
genotyping. However there are disadvantages. There is a bias based on the 
selection of participants for the association study. The relative risk is also an 
estimate based on the population stratification which can lower detection power of 
genotyping (Hirschhorn & Daly, 2005). A major shortcoming of this type of study 
is its potential for false-positives and negatives because of the large number of 
statistical tests that are performed (Hirschhorn & Daly, 2005). In any event this 
type of analysis is critical to initial discovery of genetic variants related to 
common diseases as well as Quantitative Trait Loci (QTL) (Hirschhorn & Daly, 
2005). Numerous steps such as careful selection of study participants, inclusion of 
certain statistical tests have been implemented in these studies to ensure true 
association of disease and reduce rate of falsehood.  
 
8. Human Population Diversity 
 
GWS have been used to reconstruct the evolutionary history of human 
populations. This has led to the completion of sequencing of the human genome in  
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2003 which provides a diverse map of human population evolution. 
 
The GWS have numerous applications but the most versatile is the use of SNPs to  
study diseases. Single Nucleotide Polymorphisms (SNPs) within human genome 
(Hutchenson et al, 2007). SNPs occur at one out of every thousand base pairs 
(Syvanen, 2001) but recent evidence shows that this frequency is much higher, 
between 0.03 % to 0.01 % in certain blocks of genes (Sabeti et al, 2007). The 
consequence of detecting and characterizing SNPs are varied. The variations can 
result in a change of phenotype; it can also change the susceptibility of certain 
individuals to other diseases. SNP is in the regulatory or coding region result in 
synonymous or non-synonymous changes (Syvanen, 2001). Synonymous changes 
result in a change of nucleotide but not amino acid. Non-synonymous changes are 
classed as being missense, conservative or non-conservative mutations. They may 
also cause the formation of a premature stop codon.  
 
Mendel‟s postulates state that there is an independent assortment of genes so that 
each individual/offspring has an equal chance of inheriting either gene of a pair. 
Bearing this in mind it leads to the conclusion that these genes are in linkage 
equilibrium. Though, when genes are inherited more often than chance then these 
genes are said to be in linkage disequilibrium (VanLiere & Rosenberg, 2008). 
Often genes and SNPs are inherited as part of a unit with other genes which lie 
close to it. This unit is referred to as a haplotype. This Linkage Disequilibrium 
(LD) has an important part to play in genetic studies because it can be used to 
infer the role of SNPs in disease.  
 
That being said these GWS had revealed European populations had linkage 
disequilibrium extending 60kb from common alleles (Reich et al, 2001). This, 
however, is the subject of much debate. The LD in Europeans extends over a 
longer distance compared to Africans (Reich et al, 2001, Jakobson et al, 2008).  
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Variation and demography play a vital role in linkage disequilibrium. SNPS 
within 10Kb of each other are in strong linkage disequilibrium (Goldstein &  
Weale, 2001). A study of the linkage disequilibrium within these two populations 
showed that in a European population the linkage disequilibrium extends over a 
greater distance. In the Nigerian population the linkage disequilibrium is much 
less. This is directly related to the events of population structure. This conclusion 
supports the idea that ancestral European populations stem from Africa and that. 
The populations have undergone genetic drift when they migrated out of Africa. 
In so doing the ancestral haplotypes were limited and have consequently given 
rise to all the present day haplotypes seen in European populations (Jakobson et 
al, 2008).  
 
In contrast to the rest of the world, Africa has the largest genetic diversity both 
within and among populations due to the historically high population size. The 
analysis of autosomal markers, the Y-chromosome and mitochondrial DNA 
among Africans, European and Asian populations showed the Fst (measure of 
population co-ancestry) is the highest in Africans (Jorder et al, 2000). 
Consequently, there are a greater number of variable genes and alleles in Africans 
(Tishkoff & Williams, 2002 and Jakobson et al, 2008). In comparison Non-
African, populations do not have high genetic diversity predominantly due to 
genetic drift, which occurred during the migration of modern humans out of 
Africa and resulted in a small population (Tishkoff & Williams, 2002). It is 
estimated that Africa has approximately 2000 ethnically diverse groups. Thus one 
can see the shortfall of candidate gene studies is that not all these populations 
have been characterized therefore the genetic diversity may be under represented. 
 
Therefore applying GWS to detect the association of SNPs in HIV can be very 
valuable in Africans because local patterns of LD have been characterized across 
the genome for Sub-Saharan South Africans (Donfack et al 2005). The genetic 
substructure of seven South African populations, Zulu, Xhosa, Tsonga, Sotho,  
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Pedi, Tswana, and Venda, was assessed by studying the Y-chromosome and the 
autosomal DNA of these populations (Lane et al, 2001). The Y-chromosome is a 
good indicator of inherited variation within and across populations because the Y-
chromosome is inherited only by males from their fathers. In essence the Y-
chromosome gives an indication of how males influence the gene pool. The 
contribution of females and males is assessed by the autosomal DNA. The Zulu, 
Xhosa, Pedi, Sotho, Tswana and Venda groups are linguistically similar in origin 
and are seen to cluster together in the constructed phylogeny. The measure of 
population structure, Fst, was very low, indicating these population groups 
although linguistically diverse share more than 98% of their genetic variation, 
suggesting that they all share a common ancestor. Thus because of the large 
genetic diversity there may be a greater number of restrictive HIV alleles and 
these will be able to be located with precision because of the low LD in African 
populations. As mentioned before the selection of the study participants thus the 
population structure is critical in determining the success of the association study. 
Population history is very important in dissecting disease causing variants and the 
issue of racially biased genes in disease has compounded the quest for answers. 
There has been some favour given to the theory that certain traits are racially 
biased (Mountain & Risch, 2004). Historically race has been classified according 
to biological factors such as skin colour, morphology. This in itself is complicated 
and not always correct; traits that produce phenotypic differences are a result of 
genetic component adapting to the environment in which an individual lives. In 
contrast ethnic races are clustered in groups but this is a consequence of the 
geographic expansion of population out of Africa (Tishkoff & Kidd, 2004). This 
expansion has not given rise to any race specific genes. Nevertheless, the 
manifestation of certain degrees of the same condition in different ethnic 
populations does make this assumption attractive. 
 
The human population adaptation to the virus shapes the evolution of the genome  
therefore it is important to dissect the structure and evolution of specific  
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populations. This has become increasing important when looking into the 
evolutionary forces that HIV exerts in populations. Infectious agents like HIV 
elicit different responses in different individuals leading to a difference in 
response to pathogenic agent. (Cooke & Hill, 2001). In the study of malarial 
infection in different West African populations, one group had increased 
immunity to the disease. Scientific evidence reveals a similar situation with 
individuals infected with HIV. A relatively small percentage of individuals are 
resistant to initial infection from HIV even though they form part of a high-risk 
group. Other individuals are not resistant to initial infection but the rate of 
progression to AIDS is delayed. These long-term non-progressors remain 
asymptomatic for 15 years or longer. Other HIV positive individuals develop 
AIDS in as little as 3 years (Carrington et al, 2001). Thus, the life expectancy of 
patients is dependant on numerous factors such as genetic make-up, immune 
response to HIV, CD4 + cells in the blood and the pathogenicity of the infecting 
virus.  
 
The innate cellular defence system is crucial in detecting and limiting infection. 
APOBEC3G is part of this system and was discovered via the candidate gene 
approach. Non-permissive cells which possess APOBEC3G allowed for an 
antiviral phenotype that was overcome by viral protein Vif (Sheehy et al, 2000). 
APOBEC3G can function independently of its enzymatic activity. In essence the 
enzymatic activity can be dissociated from the other cellular functions of 
APOBEC3G. 
 
9. Genetic organization of APOBEC3G 
 
This gene has eight exons, all of which are transcribed, arranged in tandem  
(Jarmuz et al, 2002). Exons 2, 3, 4 are duplicated within exons 5, 6, 7, 
respectively. The duplication results in the presence of two active sites (exons 2, 
5), two linker regions (exons 3, 6) and two psuedocatalytic domains (exons 4, 7)  
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(Jarmuz et al, 2002). The active site is responsible for target binding and 
specificity. It contains a zinc-finger motif where zinc-binding ligands such as 
histidine, glutamic acid, proline and cysteine are critical for the functioning of the 
putative deaminase. The two aromatic amino acids phenylalanine and tyrosine are 
responsible for the binding of the target to the active site (Jarmuz et al, 2002). 
Point mutations in the zinc-finger motif diminished the activity of APOBEC3G, 
once again illustrating the importance of this domain in establishing an antiviral 
phenotype in the absence of Vif (Mangeat et al, 2003). The psuedocatalytic 
domain however lacks the zinc-binding ligands and thus has no target binding 
abilities. It is hypothesized that this domain may stabilize the hydrophobic core of 
the active site in addition it may bind auxiliary factors essential for deamination 
(Jarmuz et al, 2002). 
 
Promoter elements serve as recognition sites for the binding of DNA proteins 
which are known to control gene expression mostly at the level of transcription 
but also through mRNA processing and translation. Typically, there is a 5‟-
TATA-3‟ box at -10 base pairs (bp) and a further promoter element at – 25 bp. In 
addition to these elements, a third element 5‟-CAAT-3‟ region is located at -80bp 
(Klugg & Cummings, 1997). APOBEC3G does not contain the elements at -10 bp 
and -25 bp but the 5‟-CAAT-3‟ region is present at -75 bp. Although APOBEC3G 
does not have the typical promoter elements it has other distinct elements located 
upstream of the open reading frame directing the transcription and translation of 
the exons. A 1025bp sequence upstream of the transcription initiation site displays 
constitutive promoter activity (Muckenfuss et al, 2007). The activity of this 
promoter was dependant on a sequence about 78-87 upstream of transcription  
initiation (Muckenfuss et al, 2007). It is at this site that transcription factors are 
bind and induce transcription. This box is termed the GC box. 
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10. Evolution of the gene family 
 
APOBEC1 was the first member of this family to be described. Its crystal 
structure and gene organization were based on E.coli cytidine deaminase. 
Homology modelling revealed that by removing the some sequences of 
nucleotides termed the gaps from E.coli cytidine deaminase (ECCDA) the 
signature sequence of APOBEC1 was derived (Chester et al, 2000). Homology 
modelling works by alignment of the amino acid sequence of the catalytic 
domains of the ECCDA and then Apobec proteins‟ amino acid sequence is fitted 
to these domains (Huthoff and Malim, 2005). Other approaches have been used to 
elucidate the structure and evolution of APOBEC proteins. In one instance, DNA 
and protein sequences of all deaminases were pooled from BLAST searches 
(Conticello et al, 2005). The BLAST searches focused on the deaminases that had 
the first cluster of the active site which contained a single zinc ligand. These 
sequences were then used to construct a phylogenetic tree. From these trees the 
AID/APOBEC family was very distinct from other cytidine deaminases as they 
contained the characteristic zinc coordinating domain (Conticello et al, 2005). 
AID/ APOBEC1/APOBEC3 were clustered together and have diverged from 
APOBEC2. APOBEC2 and AID had homologs that could be traced back to bony 
fish. However APOBEC1 did not have any non-mammalian homologs, suggesting 
that it was actually derived from AID. In addition, APOBEC2 was an ancestral 
sequence from which the other members of the family have diverged (Conticello 
et al, 2005). There are nine paralogs of APOBEC3G in the humans. 
 
 It has been proposed that APOBEC3 zinc domains were the result of the  
diversification of two ancestral domains that either constituted a double-domained 
protein or a single domained protein such as APOBEC3 A and H (Conticello et al, 
2005).  
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11. Deaminase independent activity of APOBEC3G 
 
APOBEC3G antiviral activity is not correlated with its deamination ability. 
APOBEC3G has an effect at every stage of viral replication. On entry into the cell 
the APOBEC3G physically blocks the reverse transcriptase from moving along 
the template (Chiu & Greene, 2008). This inhibition is not always complete and 
rather decreases the production of reverse transcripts. APOBEC3G may be 
expressed in two forms (Goila-Gaur and Strebel, 2008). It is packaged into high 
molecular weight ribonucleotide complexes (RNP) in resting CD4 cells in the 
lymphoid tissues by cytokines (Gallios-Montbrun et al, 2006), localized within the 
cytosol of the cells. When APOBEC3G is associated in this form it cannot block 
integration and reverse transcription of the virus. In contrast, resting CD4 cells in 
the peripheral blood are not permissive to HIV infection because APOBEC3G is 
packaged into low molecular weight ribonucleotide complexes (Goila-Gaur and 
Strebel, 2008) which block integration and reverse transcription of the virus, 
independent of the editing mechanism (Gallios-Montbrun et al, 2006). In essence 
the enzymatic activity can be dissociated from the other cellular functions of 
APOBEC3G 
 
12. Deaminase dependant activity of APOBEC3G 
 
Inhibition of viral reverse transcription is not completely negated via the 
independent pathway and viral DNA does enter the cell and is transcribed (Chiu 
& Greene, 2008). In so doing a viral minus strand is generated and deamination  
occurs. Deamination is the conversion of cytidine in RNA to a uridine of the first 
strand reverse transcripts in target cells. This results in G-to-A hypermutation in 
the coding strand and is associated with premature DNA degradation. The 
deamination of the cytosine will result in one normal C: G pair and the mutated 
pair (U: A) (Sousa et al, 2007). The mutated pair will be fixed in subsequent 
generations as T: A. Viruses are sensitive to the incorporation of uracil and have  
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subsequently developed a mechanism to ensure the removal of the uracil and the 
propagation of the virus. After the incorporation of the uracil, it may also be 
removed by uracil DNA glycosylases, leading to the cleavage of the sites by an 
endonuclease and subsequent viral degradation as a result of DNA fragmentation. 
cDNA complementation does occur after deamination but that the synthesized 
DNA is degraded before integration into the host genome (Mangeat et al, 2003). 
Thus the G to A mutation functions to curb the spread of the virus (Harris et al, 
2003). Mutations are produced at dC dinucleotides or pools (Harris et al, 2003). 
Thus they occur at hotspots which are preceded by 5‟pyrimidine-dC consensus. 
Hypermutation may function to diversify expressed sequences. Hypermutation is 
common in mammals and plays a vital role in normal processes within the body 
such as antibody diversification in B lymphocytes. This mechanism of C-to-U 
substitution editing mechanism is similar to the editing of apo mRNA editing and 
the Apobec-like protein editing.  
 
13. Selection of APOBEC3G and Vif  
 
The interaction between APOBEC3G and vif is antagonistic. APOBEC3G is under 
a positive selection pressure to decrease the activity of the Vif, while vif is 
adapted to enhance the relationship between the two. This antagonistic 
relationship drives the process of evolutionary change.  
 
In permissive cells infected with vif defective HIV, APOBEC3G is packaged into  
the virions. The virions on contact with a new cell infect the cell and the minus 
strand cDNA is used to synthesize DNA. The encapsidated APOBEC3G then 
deaminates the newly synthesized DNA at specific cytosine residues to uracil. The 
unstable DNA fails to integrate into the host genome to form a provirus and it is 
consequently degraded. Wild type virus that infects non permissive cells ensures 
that vif binds to APOBEC3G, blocking uncoating of the virus and thus preventing 
deamination. 
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The structure of human APOBEC3G was discerned by modelling it on the outer 
monomer of Apobec 2. This model fitted the predicted secondary structure. In 
addition, this model allowed confirmation of the residues important in the 
functioning of the APOBEC3G. Specifically, the D128 residue, previously found 
to be important in determining species specificity in vif mediated inhibition of 
APOBEC3G. Comparative sequence data from non human primates such as Old 
world monkeys (OWM) New world monkeys (NWM) and hominids indicate that 
APOBEC3G was under positive selection pressure in primates for at least 33 
million years. This positive selection pressure is the driving force for the fixation 
of variants with altered proteins. This ultimately affects how the gene variants 
interact with one another. Interestingly the selection pressure appears to be ancient 
(Sawyer et al, 2004). APOBEC3G in Old world monkeys and hominids appears to 
have diverged from each other 23 million years ago (Sawyer et al, 2004). The new 
world monkeys, old world monkeys and hominids shared a common ancestor 33 
million years ago (Sawyer et al, 2004). This selection is not limited to a specific 
domain. It appears that different domains within the APOBEC3G proteins have 
been selected in different primates through the years. Residue D128 of 
APOBEC3G contributes a negative charge to the cluster under positive selection. 
The 3D modelling confirmed what Huthoff and Malim (2005) postulated that the 
position of this residue allows the direct interaction of APOBEC3G with vif. Two  
functionally important residues emerge R122 and W127. Mutations in these 
residues show that these mutants failed to inhibit HIV-1 in vif defective virions as 
APOBEC3G is not packaged into these virions (Zhang et al, 2007). Residues 124-
127 are aromatic and have been implicated in having an important role in the 
incorporation of APOBEC3G into the virion (Huthoff and Malim, 2007). It is 
thought that the positive selection of APOBEC3G is favored by the changes in 
charge of the amino acid. This is supported by the fact that the Asp 128 is 
conserved in hominids and Lys 128 is conserved in OWM. When the aspartic acid 
in the human APOBEC3G is replaced with the lysine that is found naturally in 
African Green Monkey APOBEC3G, it becomes resistant to HIV-1 vif but not  
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SIV vif (Zhang& Webb, 2004). Having said this it is very hard to ascertain the 
exact driving evolutionary force acting on this gene. The gBGC is unlikely to be 
the explanation for the high number of non-synonymous polymorphisms (the 
hallmark of positive selection) in APOBEC3G because it favours the fixation of 
advantageous GC to AT mutations. In contrast APOBEC3G functions by 
converting uridines to cytosines ultimately leading to the production of G to A 
mutations in the plus strand of the viral DNA. It is possible to conclude that the 
interaction between APOBEC3G and vif is the driving force for this selection. 
They act in an antagonistic manner with each other and so it is reasonable to 
assume that APOBEC3G evolution should be considered in conjunction with that 
of vif. 
 
 14. Interaction of APOBEC3G and Vif 
 
Vif has a three fold action on APOBEC3G. It can bind to it and target it for 
degradation by proteosomes. It can mediate its destruction via polyubiquitination 
and stop encapsidation of the APOBEC3G into newly produced virions in the 
absence of degradation. The region of APOBEC3G implicated in this binding of 
Vif is the amino terminal (Zhang et al, 2008). The process is detailed below. 
 
The most complex function of Vif is its inhibition of APOBEC3G via 
polyubiquitination. Ubiquitination is proteolytic modification of proteins with 
ubiquitin. E1, E2, E3 enzymes are involved in the covalent conjugation of 
ubiquitin to a substrate consequently ensuring that the protein is degraded by the 
proteosome. Classically ubiquitination is divided into three stages: Activation, 
Conjugation, and Ligation. Initially there is activation of ubiquitin with ATP by 
ubiquitin-activating enzyme E1. Following this, the activated ubiquitin is 
conjugated to E2 via a thioester bond. E2 acts with E3 to transfer the ubiquitin to 
the target. An isopeptide bond is formed between the terminal lysine of the 
substrate and the C-terminal glycine of the ubiquitin. The target is poly- 
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ubiquinated and is tagged to be degraded by the 26S proteosome. This method of 
ubiquitination is relatively conserved even though all the components are of 
ubiquitination may not be characterized. 
 
Vif interacts with cellular proteins Cul 5, elongin B & C and Rbx1 (He et al, 
2008). Vif is probably the F-box protein, which determines target specificity. 
These proteins form SCF-like complex, more specifically, it bears resemblance to 
the VCB-like complex. Both of these complexes belong to an E3 ubiquitin ligase 
super-family. These complexes are biologically important as they selectively bind 
and ubiquinate specific proteins, targeting them for destruction (Yu et al, 2003). 
They are also vital in regulating and stabilizing signal transduction pathways and 
maintaining the cell cycle. Over-expression of Rbx1 in the presence of 
APOBEC3G decreased infectivity of the virus and Cul 5 inhibited ubiquitination 
of APOBEC3G. Vif interacts with this complex via a conserved motif SLQXLA 
because mutations in this motif drastically reduced the interaction between Vif 
and SCF-like complex (Yu et al, 2003, Mehle et al, 2006). Although mutations in  
this motif reduced interaction with the complex, it did not effect the interaction of 
Vif with APOBEC3G. This is direct evidence that Vif activity alone is not enough 
to overcome the antiviral action of APOBEC3G. However, the cellular target of 
the SCF-like complexes remains elusive. Proteosomes have also been implicated 
in Vif functioning. When a proteosome inhibitor is added to non-permissive cells 
Vif failed to exclude APOBEC3G from the resulting progeny and the viruses were 
weakly infectious (Yu et al, 2003). Thus, Vif in conjunction with SCF-like 
complexes and proteosomes are essential in suppressing host antiviral phenotype. 
 
Vif is established to interact closely with the components, which are collectively 
termed as an E3 ligase. They are said to be an E3 ligase as they have a similar 
structure to the SCF complexes. Rbx1 was an important component of the 
complex and interacted intimately with Cul 5 as seen in mutagenesis studies. Cul 
5 mutants with no Rbx1 binding affected the production of infectious virions in  
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non-permissive cells (Yu et al, 2003). Vif associates with the E3 ligase by means 
of a conserved SLQ motif (Yu et al, 2003). Mutation in this motif decreased the 
association of Vif with E3 ligase but not with APOBEC3G. Consequently it is 
speculated that Vif interacts with the ligase and simultaneously with APOBEC3G 
acting as a bridge between the two facilitating ubiquitination. The N terminus of 
Vif binds APOBEC3G via its N terminal residues 54 -124. The zinc binding 
domain of Vif has two conserved cysteine that bind Cul5 (Mehle et al, 2004). 
 
 
Figure 2. The interaction of Vif and APOBEC3G in non-permissive cells. 
 
The dimerization domain of vif is functionally important in blocking the 
incorporation of APOBEC3G into virions (Miller et al, 2007). This “proof of 
concept” was proved by using antagonists against Vif dimerization the 
dimerization of vif is localized to the SQL motif with Vif. The agonists disrupted 
the expression of vif in addition to the dimerization of vif (Miller et al, 2007).  
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This disruption facilitated the incorporation of APOBEC3G into the newly 
produced virions and subsequently HIV infectivity was decreased. The regulation 
of the APOBEC3G by vif is also mediated by functionally important residues such 
as amino acid 124 to 127. These are integral to packaging the APOBEC3G into 
virions while the amino acid 128 determines species specificity. APOBEC3G 
variants have a profound influence on the progression to AIDS in a cohort of 
seroconverter, seropositive, seronegative participants of European and African 
American descent. Seven SNP were identified within the gene. Three were in the 
putative regulatory region (-571, -199, -90), one the codon 3 (F119F), one in exon 
4 (H186R) and two within the introns. This study revealed through haplotypes 
analysis that there are six frequent haplotypes which cause these SNPs to be 
inherited together. Of particular interest is the frequency of substitution of 
histidine to arginine in amino acid position 186 was higher African Americans 
than European Americans. In particular the 186R allele was associated with faster 
progression to AIDS in the African Americans (An et al, 2004).The frequency 
was 37 % in African Americans as compared to 2, 9 % in European Americans 
(An et al, 2004). However, these observations have not being independently 
confirmed in other studies. A recent study investigated this polymorphism in 
Indians. The 186 R allelic variant could not be found in the study sample and thus 
not conclusions could be drawn about its influence on disease progression in this 
study population (Rathore et al, 2008). 
 
One must study the effects of important genes in Africans to gain the correct and 
comprehensive picture of disease pathogenesis. APOBEC3G is a good candidate 
for HIV restriction because it allows the expression of an antiviral phenotype in 
non-permissive cells consequently this innate immune defence is an alternative in 
the design of new therapies. In addition, polymorphisms in the host factors 
characterized in genetic studies are found predominantly in the promoter region or 
regulatory regions. Hence, this region is a good starting point to investigate the 
variation in APOBEC3G and its contribution to HIV/AIDS pathogenesis. In  
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addition numerous variants which modulate HIV pathogenesis have been  
discovered by sequencing the upstream non coding region such as the Duffy 
Antigen Receptor for Chemokines (DARC) (Winkler et al, 2004). 
 
15. Aim 
 
The aim of the project was to describe variation in APOBEC3G. The objectives 
included the characterization of variation of APOBEC3G in Bantu-speaking South 
Africans with particular emphasis on the non-coding region of APOBEC3G. The 
non-coding region is known to be important in determining the functional variant 
produced as it controls transcription, translation and processing events of a gene. 
 
16. Objectives 
1) Analyze sequence data from sequences received in Honours. 
2) Develop genotyping assays for -571 SNP in the upstream non-coding 
region and H186R in the coding region of APOBEC 3G.  
3) To determine allele and genotype frequencies of the two SNPs. 
4) To determine linkage disequilibrium of the SNP data and to infer 
haplotypes. 
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Materials and Methods 
1. Sampling 
1.1.Sample collection 
The search for variation in APOBEC3G was carried out using blood samples from 
Bantu-speaking South Africans. Samples were collected from patients at The 
Infectious Disease Clinic at Johannesburg General Hospital and from the Themba 
Lethu Clinic at Helen Joseph Hospital. A subset of 45 samples was collected from 
a general population of Bantu-speaking South Africans surrounding University of 
the Witwatersrand. Data was collected on geographic origin of participants, their 
parents and grandparents and in addition, specifics such as age, recent CD4 
+ 
T 
cell count, date of first infection and secondary illnesses was also gathered from 
the participants. Ethics clearance has been obtained from the Human Research 
Ethics Committee. The clearance number is M040221 (Appendix). 
 
As the origin of most South Africans stems from the Bantu expansion 2000 years 
ago, the Bantu-speaking subpopulations found today are still genetically similar 
(Lane et al, 2002). Within the samples it was found that in 57 % there was one 
language present over three generations, 31 % of the recent ancestors were mixed 
with respect to language. In 7.4 % of the sample population the language across 
all three generations was incomplete. 3.7 % of the sample was mixed with respect 
to ethnicity. Within the sample group that has a single language across all three 
generations, Zulu is the most frequently sampled at 45.4 %. At 15.6 % the Xhosa 
ethnicity is the second frequent within this grouping, this is followed closely by 
Tswana and Sotho languages both occurring at a frequency of 11.7 %. The Pedi 
language group accounts for 6.5 % of the sample in this subgroup, with Venda, 
Ndebele and Tsonga representing 3.9 %, 2.6 % and 2.6 % respectively. Therefore 
the Bantu-speaking Johannesburg population is representative of the major Bantu-
speaking ethnic groups in South Africa. Thus, the sample is adequate as it 
provides an estimation of variation present in HIV/AIDS patients in the province. 
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1.2. Privacy and confidentiality 
 
Privacy and confidentiality was observed throughout the sample collection 
process. Discussions with patients took place in a vacant doctor‟s room in the 
clinic. To ensure confidentiality numerous steps will be taken: 
 *Codes were used instead of participants‟ names 
*Information shared with the investigator was not disclosed with a third party. 
 *Information was sealed at all times in a locked cabinet. 
 
1.3. Informed consent 
 
Participants were required to fill in consent forms (Appendix). It was instrumental 
that the participants gave voluntary informed consent. To ensure this numerous 
steps were taken: 
 *An explanation of the project and the consent form was undertaken in a 
language preferred by the participant. 
 *Written and oral explanations were provided in a manner that was easily  
understandable to the participant. 
 *Participants were given the opportunity to ask questions and only then did they 
sign the consent forms. 
 
1.4. DNA extraction 
 
Genomic DNA extraction was performed at Medical School and at the P2 facility 
in Molecular and Cell Biology using the Qiagen DNA Blood Mini kit. The 
Vacutainer
® 
tubes used to collect and store the blood had EDTA, which prevents 
the blood from clotting. Genomic DNA was extracted from the white blood cells 
in the buffy coat, which is the middle layer when blood that has been centrifuged  
for 10 minutes at 13.4 rpm. Initially the blood was lysed with an ethanol-
containing buffer. This was followed by the addition of protease and RNase. The  
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protease degraded any proteins and the RNase eradicated any traces of HIV virus. 
The solution was then added to spin columns. This facilitated the binding and 
elution of the DNA from silica particles. Washing with an ethanol-containing 
buffer ensured that any impurities such as divalent ions and proteins were 
removed so that pure DNA could be eluted from the membrane. DNA was eluted 
with another buffer and was concentrated by using a smaller volume of buffer. 
This DNA was used to detect variation in the APOBEC3G gene.  
 
2. Analysis of upstream non-coding region sequences 
2.1 Analysis of sequence data 
 
In my BSc (Honours) project of 2003 I sequenced the upstream non coding region 
of APOBEC3G. This variation was detected by direct sequencing and analysed 
using Sequencher 4.0. The analysis was very rudimentary. Hence as more insight 
was gained regarding the gene and software it became evident that these 
sequences need to be re-analyzed now. 
 
2.2 Promoter analysis 
 
All eukaryotes contain promoter elements upstream of the first open reading 
frame. Promoter elements serve as recognition sites for the binding of DNA 
proteins which are known to control gene expression mostly at the level of 
transcription but also through mRNA processing and translation (Muckenfuss et 
al, 2007). 
 
Software such as FPROM, TSSG, TSSW were employed to search for promoter  
elements using the sequenced data from 2003. FPROM, TSSG, TSSW allows for 
the recognition of human POLII promoter region and the start of transcription. 
The algorithm is based on the recognition of functional motifs as well as 
nucleotide sequence of genes (Solovyev and Salamov, 1997). The interesting  
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point is these programs were modeled using microarrays to search for functional 
enrichment of transcription binding sites (Solovyev and Salamov, 1997). The 
output file included the number and position of the transcription start sites, their 
relative weights and the TATA box position (if any). In addition TSSG and TSSW 
predicted the transcription factor binding sites for the Transcription Start Sites 
(TSS). 
 
3. The genotyping of position -571  
3.1 Detection of SNP -571 using Allele Specific Amplification 
 
Polymerase Chain Reaction (PCR) is a relatively easy method used for amplifying 
DNA. The method is so sensitive that a single DNA molecule can be amplified 
and consequently visualized on an agarose gel as bands. The use of thermo stable 
DNA polymerases and automation of the method increases its efficiency. As a 
result many PCR applications have been developed. These include screening and 
sequencing of inserts from phages and bacteria and the visualization of single-
copy genes. There are three main steps in PCR, denaturation, annealing and 
extension. Initially double stranded template DNA is denatured. This is termed a 
hot start. This is then followed by a ramp down to the annealing temperature 
where primers anneal to their target sites. Lastly extension of the primers, with 
nucleotides, by DNA polymerase is performed. Primer design is crucial in PCR 
and numerous things have to be taken into consideration in order to yield 
successful results. Primers should have GC content between 40 % - 60 %. The 
higher the GC content the more stable the primers. The primers should have a  
length of between 18 nucleotides and 30 nucleotides. The primers should not be 
self complementary or complementary to each other. If primers are self-
complementary they will fold back and bind on themselves. If complementary to 
each other they will bind to each other and not to the annealing sites on the target 
molecules resulting in inefficient or no amplification.  
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The APOBEC3G gene was accessed using Pubmed and the accession number 
(NT011520). To detect variation of the -571 SNP Allele Specific Amplification 
was used. Allele Specific Amplification was used as an alternative to direct 
sequencing because it is applicable to a large number of samples and is therefore 
inexpensive. In Allele Specific Amplification (ASA) both primers have the 
identical sequence except the base at the 3‟end is different for each primer 
(Okayama et al, 1989). Each primer will have one alternative for the SNP at the 3‟ 
prime end. Homozygotes will only yield PCR product with either primer. 
Heterozygotes will yield a product with both primers (Okayama et al, 1989). 
 
The reaction mixture for the PCR consisted of 2X Fermentas Master Mix 
(0.05 u/µl Taq DNA polymerase (recombinant), reaction buffer, 4 mM MgCl2, 
0.4 mM of each dNTP (dATP, dCTP, dGTP, and dTTP). Primers were diluted to 
give a stock concentration of 2 μg/μl (mass (μg) + 0.5 (mass (μg) TE) and a 
working solution of 20 ng/μl (2 μl stock soln + 198 μl water). 
 
The cyclic conditions for -571G PCR is denaturation at 94°C for 2 min, this is 
followed by 35 cycles of denaturation at 94°C for 30s, annealing temperature at 
63°C for 25 s, extension at 72 °C for 18 s, the final extension is at 72°C for 5 
minutes. The cyclic conditions for -571C PCR is denaturation at 94°C for 2 min, 
this is followed by 35 cycles of denaturation at 94 °C for 30s, annealing 
temperature at 63.5°C for 25 s, extension at 72°C for 20 s, the final extension is at  
72°C for 5 minutes. The PCR products were then visualized on a 1% agarose gel 
stained with ethidium bromide. The gel was run at a constant voltage of 70V for 1 
hour. Thereafter the agarose gel was visualized on the UV transilluminator at 
wavelength 254 nm.  
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Table 1: Primer set sequences used in ASA, annealing temperatures, and size of 
product sequence 
Primer Primer Sequence SNP Annealing 
temperature 
Product 
size 
 
-571 G 
 
PCR Reverse 
 
5 „CGCCATGGGAACACGCTACCAG 3‟ 
 
 
TGAAGCCTCACTTCAGGTACC GCTGC 
 
-571G 
  
63 C 
 
850 bp 
 
-571 C 
 
PCR Forward 
 
5‟GCGCGTCTCACAGCTCCCTTCCCG 3‟ 
 
 
AGTTCACAGGGGTCACAATGGCT 
 
-571C 
 
63.5 C 
 
450 bp 
 
3.2 Detection of SNP -571 using Restriction Fragment Length Polymorphism 
(RFLP) 
 
A gradient PCR facilitated the selection of the optimal annealing temperature for 
the amplification of product. The PCR master mix reaction is the same as for 
conventional PCR. The difference is that the PCR heat block where the PCR tubes 
are placed is divided into different temperature zones which are selected by the 
user. The PCR is setup for one sample for each temperature zone tested. 
Essentially the same sample can be amplified using different annealing 
temperatures at once there by reducing time. 
                                            1     2    3    4    5    6    7   8 
 
 
Figure 3: PCR Heat Block. Letters A, B, C, D represent the different temperature zones. 
Row A would have one temperature; row B another temperature and so on. Eight samples 
can be loaded in each row. 
 
A 
B 
C 
D 
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The reaction mixture for the PCR consisted of 2X Fermentas Master Mix 
(0.05 u/µl Taq DNA polymerase (recombinant), reaction buffer, 4 mM MgCl2, 
0.4 mM of each dNTP (dATP, dCTP, dGTP, and dTTP). Primers were diluted to 
give a stock concentration of 2 μg/μl (mass (μg) + 0.5 (mass (μg) TE) and a 
working solution of 20 ng/μl (2 μl stock soln + 198 μl water). 
 
The cyclic conditions for the gradient PCR is denaturation at 94°C for 2 min, this  
is followed by 35 cycles of denaturation at 94°C for 30s, annealing temperature of 
between 60°C-58°C for 30 s, extension at 72°C for 30 s, the final extension is at  
72°C for 5 min. The PCR products were then visualized on a 1% agarose gel 
stained with ethidium bromide. The gel was run at a constant voltage of 70V for 
45 minutes. Thereafter the agarose gel was visualized on the UV transilluminator 
at 254 nm. 
 
Once the gradient PCR established the optimal annealing temperature, this 
temperature was used to amplify the subsequent samples using the PCR reaction 
mixture as above and then visualize after being run on a 1% agarose gel at 70 V 
for 1 hour. Successful samples are then subjected to restriction digestion to 
RFLPs. The restriction digestion was optimized by using sequence samples with 
known nucleotide sequence for GG and GC genotypes. The optimization did not 
include a control for the CC genotype as only one was found by direct sequencing 
and DNA for this sample was finished. 
 
The RFLP technique was also used to detect variants of SNP -571. RFLP is a 
difference in the DNA sequence of a genome which when cut with a restriction 
enzyme will yield fragments of differing size which are separated and visualized 
on an agarose gel. This method can be used to determine genotypes because each 
combination of alleles will produce a predicted pattern of fragments. RFLP is 
especially helpful in detecting known SNPs in the genome in large sample set and 
thus also inexpensive when compared to direct sequencing. 
 
34 
                                                                   
 
 
The reaction mixture consisted of 10 X Buffer R with BSA, 2.5 μ/ μl MvaI, 6 μl 
product and nuclease free water. The digestion was carried out for 4 hours at 
37°C. The product was run on a 4% agarose gel stained with ethidium bromide for 
2 hours at 70V. The gels were visualized with the UV transilluminator. The  
individuals homozygous for the C allele will have three bands present at 215 bp, 
114bp and 49 bp. Those homozygous for the G allele will have 215bp, 163 bp 
bands present. The heterozygotes will have four bands present (215bp, 163bp, 
114bp and 49 bp) (Figure 4). 
 
 
 
Figure 4. Schematic of three genotypes of position -571 of the upstream non-coding 
region after digestion by restriction enzyme MvaI. 
 
4. Detection of variation in exon 4 using Pyrosequencing 
  
Pyrosequencing technology is based on sequencing. It is based on a 4-enzyme 
real-time monitoring of DNA by bioluminescence. Essentially there are 4 
reactions that ultimately result in the quantitation of a light signal and a sequence 
of synthesized strand of DNA (Ahmadian et al, 2005). For pyrosequencing the 
sequence surrounding SNPs is known and only the dNTP that matches the  
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sequence is added to the reaction and it pairs with the sequencing template and an 
inorganic pyrophosphate is released. The tagged amplified fragments serve as the  
template for the universal primer. The released phosphate serves as a template for 
ATP sulfurylase to produce ATP. ATP is converted to light by luciferase 
(Ronaghi, 2001). The unincorporated nucleotides and ATP are removed from the 
reaction by Apyrase (Ronaghi, 2001). This is crucial in ensuring that the light 
signal is only the result of the correct base being added. The sequence is 
consolidated as a pyrogram where the peaks give the approximate light signal 
intensity. The light intensity is directly proportional to the sequence of the 
synthesized DNA (Ronaghi, 2001). The software produces a theoretical output of 
all possible genotypes and the pyrograms need to be compared to these to verify 
the genotypes.  
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Figure 5. Schematic overview of pyrosequencing system. When the correct dNTP is 
added it pairs with the template and light is produced. When the dNTP that is added is not 
complementary with the template, no light is produced. 
 
The simplicity of the technique allows for high throughput DNA analysis. There 
are many applications of pyrosequencing. This technique was used for genotyping 
SNPs within the coding region of APOBEC3G. The primer design is very 
important in the SNP genotyping assay. There are sequence specific primers that 
used to amplify the region of interest. The primers that were used are APOfor 
(GACGGGGACACCGCTGATCGTTTAGCAAGTTCGTGTACAGCCAAAGA) 
and APOrev (AGAGGAGCGAGGCGATGA) and were designed with the 
pyrosequencing software by Dr Zane Lombard from the NHLS. The forward 
primer is tagged at the 5‟ end with a sequence 
(GACGGGGACACCGCTGATCGTTTA) that matches the biotin labeled  
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universal primer (GACGGGGACACCGCTGATCGTTTA). Essentially the 
process is that the forward and reverse primers will amplify the region of 159 bp. 
 
After the successful optimization and amplification of the desired region the 
samples were viewed on a 4 % agarose gel to ensure the correct size and minimal 
primer dimmers. Because the forward primer was tagged the software assigns the 
genotype of the anti-sense strand. 
 
 
 
 
 
 
 
Figure 6. Position of the primers used for pyrosequencing. 
 
The reaction mixture for the PCR consisted of 2X Fermentas Master Mix 
(0.05 u/µl Taq DNA polymerase (recombinant), reaction buffer, 4 mM MgCl2,  
0.4 mM of each dNTP (dATP, dCTP, dGTP, and dTTP). Primers were diluted to 
give a stock concentration of 2 μg/μl (mass (μg) + 0.5 (mass (μg) TE) and a 
working solution of 20 ng/μl (2 μl stock soln + 198 μl water). 
 
The cyclic conditions for the PCR was denaturation at 94°C for 2 min, followed 
by 40 cycles of denaturation at 94°C for 30s, annealing temperature of 58°C for 
30 s, extension at 72°C for 30 s, the final extension was at 72°C for 5 min.  
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Figure 7. Pyrogram of variation at two positions 
 
The Ensembl database showed that there are two SNPs in this exon which reside 
next to each other; hence conventional genotyping assays such as allele specific 
PCR or RLFP may be problematic because of the proximity of the SNPs. The 
solution to this was to use pyrosequencing to discern the genotypes in the 
population and to see if the SNP upstream of H186R codon changing variant is 
also found in the Bantu-speaking South African population. 
 
 
41101 GCAGCCTGTGTCAGAAAAGAGACGGTCCGCGTGCCACCATGAAGATCATGAATTATGACG 41160 
41161 GTGAGAAGTGGGAGGTTCAGGGGTGTGGGAGAGACTGCTTAAGTGTMTGTGATGGGTCCT 41220 
41221 TCCCACACATACCTGTGGGTCTGCTCTGATGCCTGCAAAGGCCAAGTGTCCCAGGGGAGC 41280 
41281 CTGTGGGGTTGGGTCTGGCGCTGASTGTAACTAGTATCYAGAATATGTCTGGGAGGGGAG 41340 
41341 GGTCCCGAGGTCACAGAAGAGAGGCCAGCTGGGCTTGACTGCKTTCTCTCTTCTTTTTCT 41400  
41401 TAGAATTTCAGCACTGTTGGAGCAAGTTCGTGTACAGCCAAAGAGAGCTATTTGAGCCTT 41460 
41461 GGAATAATCTGCCTAAATATTATATATTACTRCRCATCATGCTGGGGGAGATTCTCAGGT 41520  
41521 GAGGGTCTCCCTCCAGGCTCATCGCCTCGCTCCTCTCACCTCCTGCTCATCCTCTTGAGG 41580 
41581 CCTCCYCTCTGTTCCAGACCAGGTCCTCTCCTGGCCAGGCCCTCCTGCCTTCCCTCCTGC 41640  
41641 CCCCTGCCTGCCCTCGTGGTTACACTCCCTCACCCACACTCCTCGTGCTCCCTCCACCTC 41700  
41701 CCTGCCTCCCACCTGCTTTCCTGGGCCCTTCCTGTGAGTGAGAGGCCCCTTCTGCCTCCA 41760 
41761 GAGCAACCTCCATCCACCCCCACAGCCTGGGAGCCCCAACCTGGCCCCTTCCATCTCCCT 
 
 
Figure 8. Excerpt from Ensembl database: ENST0000026324. Exon 4 is highlighted in 
Blue. The codon changing variant of interest is highlighted in red and yellow and another 
SNP is found in the adjacent codon. 
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5. Sequencing of exon 4  
 
 The region in exon 4 containing SNP 186 was sequenced by conventional 
sequencing to confirm the exon 4 nucleotide sequence obtained from the Ensembl 
database was correct. PCR was used to amplify a 600bp fragment was amplified 
using the following primers: Codon 4 fw 
(AAGCTGCATCGTGACCAGGAGTAT) and Aporev 
(AGAGGAGCGAGGCGATGA). The reaction mixture for the PCR consisted of 
2X Fermentas Master Mix (0.05 u/µl Taq DNA polymerase (recombinant), 
reaction buffer, 4 mM MgCl2, 0.4 mM of each dNTP (dATP, dCTP, dGTP, and 
dTTP). Primers were diluted to give a stock concentration of 2 μg/μl (mass (μg) + 
0.5 (mass (μg) TE) and a working solution of 20 ng/μl (2 μl stock soln + 198 μl 
water). 
 
The cyclic conditions for the PCR were denaturation at 94 °C for 2 min, followed 
by 40 cycles of denaturation at 94 °C for 30s, annealing temperature of 59.6 °C  
for 30 s, extension at 72 °C for 30 s, the final extension was at 72 °C for 5 min. 
The PCR products were then visualized on a 1% agarose gel stained with 
ethidium bromide. The gel was run at a constant voltage of 70V for 1 hour. 
Thereafter the agarose gel was visualized on the UV transilluminator. Two 
samples were sequenced in both the forward and reverse directions using 
sequencing primer ApoSeq1 (AGACCCTCACCTGAGA). 
 
6. Data Analysis 
6.1 Allele and Genotype frequencies. 
 
To determine the allele and genotype frequencies of the various SNPs the 
genotypes were counted. The genotype of an individual is defined as its genetic 
makeup with reference to a specific locus. Consequently the genotype frequency 
is the frequency or proportion individuals carrying a certain genotype (Hartl and  
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Clark, 1989). The allele frequency on the other hand is the measure of the 
frequency in a population of a specific allele at a given locus for that trait. 
 
If a locus is bi-allelic (i.e. it has two forms at the locus) then the frequency of the 
three possible genotypes can be represented by f (AA), f (AA), f (AA). If the 
numbers of individuals (obtained by direct counting of the three genotypes) 
carrying those genotypes is represented by x, y, z respectively. 
 
Genotype frequency of the three genotypes is calculated as follows: 
 F (AA) = x/n where n is the number of individuals present 
 
f (Aa) = y/n 
 
f (aa) = z/n 
The allele frequency is determined from the genotype frequency as follows: 
  
 Let f (A), f (a) represent the alleles frequencies of the A allele and the a allele 
respectively. Then, 
 
f (A) = (2x+ y)/2n where 2x + y is the number of A alleles 
 
f (a) = (2z + y)/2n where 2z + y is the number of a alleles 
 
6.2 Hardy- Weinberg Equilibrium 
 
The Hardy-Weinberg law predicts genotype frequencies from allele frequencies 
under certain conditions. For a population to be in Hardy-Weinberg equilibrium 
certain conditions have to hold true; there must be random mating, no gene flow 
in or out of the population, the population must be infinitely large and there must  
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be equal fertility of all genotypes (Hartl and Clark, 1989). Thus a consequence of 
this model is allele frequencies will not change from one generation to the next. 
Genotype frequencies can be predicted from allele frequencies.  
 
The model  
 
If f (A) = p, 
 
and f (a) = q, 
 
then the expected genotypes will be 
 f (AA) = p
2
 
 f (Aa) = 2 pq 
 f (aa) = q
2 
 
 
If the population is in equilibrium then, 
  
p
2 
+ 2pq + q
2 
= 1 
 
The statistical Chi-squared test (χ2) is then used to determine if the frequency of 
the expected genotypes is much different from the observed genotypes. 
 
Χ2 = ∑ (O-E)2 /E 
  
Where O = observed number of genotypes 
 E = expected number of genotypes 
 
A P value of 0.05 indicates a lack of significant deviation from the Hardy-
Weinberg Model. 
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6.3 Linkage Disequilibrium and Haplotype Analysis 
 
Linkage Disequilibrium describes the non-random assortment of alleles at two or 
more loci (Devlin & Risch, 1995). It essentially states that some genotypes may 
occur more or less frequently than would be expected if the loci were not linked. 
Often genes and SNPs are inherited as part of a unit with genes that lie in a close 
physical proximity and this is termed a haplotype. Thus measurements of LD are 
based on comparisons of genotype frequencies of haplotypes. 
 
 
Figure 9. Diagrammatic representation of Haplotypes at two loci 
 
Linkage disequilibrium was analysed using Linkage Disequilibrium Analyzer 1.0. 
This program implements the EM algorithm (Keyue et al, 2001). To explain LD 
lets consider an example. 
 
Consider two loci each with two alternative alleles on one chromosome 
 
Haplotype Frequency: 
A1 B1 x11 
A1B2 x12 
A2B1 x21 
A2B2 x22 
 
Then the allele frequency will be: 
Allele Frequency: 
A1 p1 = x11 + x12 
A2 p2 = x21 + x22 
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B1 q1 = x11 + x21 
B2 q2 = x12 + x22 
If these alleles are independent then  
x11 = p1q1 
 
 But if the alleles are not independent and there is a deviation from the observed 
frequencies compared to the expected then it is measured by a parameter D 
(Devlin and Risch, 1995). 
 
D = x11 - p1q1 
 
Allele frequencies can only be between 0 and 1. When either applies then there 
can no D. Therefore the D is normalized by dividing it with the theoretical 
maximum (0.5) of observed allele frequencies (Lewotin, 1964). 
 
 D‟ = D / Dmax 
 Where D > = 0 or D < 0 
 
Another important LD measure is r
2
. This measure informs if alleles at two loci 
are related and is often used to detect loci that influence disease susceptibility 
(VanLiere and Rosenberg, 2008). 
 
Haplotypes analysis was determined using PHASE v 2.1 (Stephens et al, 2001). 
This software implements Bayesian algorithms. 136 samples with known 
genotypes at loci -571 and H186R were used for the haplotype analysis. To obtain 
reliable results the developers suggested that at least 10 runs were done and inter 
run variability checked to ensure correct analysis. Specifically it was suggested 
that the Freq output file is checked between runs as this will provide the most 
reliable look at run performance. 
 
44 
                                                                   
 
6.4. Disease Status Association 
 
To determine whether APOBEC3G is associated to susceptibility to HIV the 
sample population was divided into HIV positive and general population. The 
genotype and allele frequencies were calculated in the sub groups and tested for 
with the Hardy Weinberg chi squared test. 
 
6.5. Independent Chi-squared test 
 
A co-dominant model was used in this test to ascertain the frequency distribution 
within the HIV + and general population. The Fishers probability will determine if 
the distribution is significant. 
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RESULTS 
 
1. Analysis of upstream non-coding region sequences 
1.1 Reanalysis of sequencing data  
 
Reanalysis of sequencing data using Sequencher 4.0 yielded numerous insights 
into the upstream non-coding region. 
 
In 2003 -91 SNP was found at a position of 91 bases upstream of transcription 
initiation. After trimming the sequences near the end of the sequences to remove 
all nonsensical sequence only 6 sequences provided informative data. Four 
heterozygotes (GC) and 2 CC homozygotes were detected. The allele frequencies 
could not be calculated for this SNP in this sample group because of the very 
small sample size.  
 
SNPs at position -163, -166 and -199 were not characterized in 2003 but re-
analysis showed it to be well represented in 18 samples. Five heterozygotes were 
observed at each position -163, -166 and -199. Heterozygote genotypes observed 
for these positions were found in the same samples. Homozygotes for the 
ancestral alleles (T) according to the dbSNP database were observed at these 
positions in the remainder of the samples. No homozygote genotypes were 
observed for the minor alleles at each SNP position (Figure 10). The remaining 13 
samples were homozygous for the major allele at all three loci. 
 
SNP at -286 was not actually a SNP. It is the result of a sequencing artifact which 
happens when G dNTP is preceded with a T dNTP in direct sequencing. 
 
The SNP at -571 was observed during analysis in 2003 and was still polymorphic. 
In 20 samples 8 were heterozygous, 11 homozygous for the C allele and 1 was 
homozygous for the G allele. The frequency of the C allele is 0.75 and the  
frequency of the G allele is 0.25 in these samples. The population diversity on the 
dbSNP shows that in Sub-Saharan population the allele frequency of the C and G  
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alleles to be 0.917 and 0.083 respectively. The difference is the result of the 
sample size and will be resolved in later discussions. 
 
At position -881 7 heterozygotes and 2 homozygotes for the allele C were 
observed. Frequency data can not be ascertained from the sequences as the sample 
size is too small 
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A 
 
 
B                                           C 
  
Figure 10. Chromatograms of re-analyzed sequences from Honours project in 2003. A) 
The chromatograms show samples 114, 142 and 131 at SNP positions -163, -166 and -
199. These SNPs appear to be in Linkage Disequilibrium as they are all either 
heterozygous at all positions in sample 114, 142 or homozygous at all position as in 
sample 131. B) These chromatograms show the artifact of sequencing which was 
erroneously interpreted as a SNP in 2003. If look at sample 114 then one can see that at 
the circled position it seems as if this sample is heterozygous for both alleles. C) 
Chromatograms showing -571 and -590 loci (purple circles). The -571 SNP is well 
represented in the samples. The chromatograms show heterozygotes and homozygotes for 
the alleles. All samples at -590 deviated from the major allele which is a G allele. Thus 
this is an example of a fixed polymorphism. 
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1.2 Promoter analysis 
  
Table 1. Genomic locations of predicted Transcription Start Sites and TATA box 
positions on APOBEC3G on chromosome 22 using three different software 
programs. 
 Promoter analysis software 
Transcription Start 
Site (TSS) on chr 22 
FPROM TSSG TSSW 
 37783673 - 37783676 
 - 37790636 37790636 
 37791680 - - 
 - 37791823 - 
 37792953 37792952 37792948 
 37793945 - - 
 37794350 - - 
 37796881 37796880 37796877 
 37797902 37797907 37797899 
 37800332 - - 
 Promoter analysis software 
TATA box position 
on chr 22 
FPROM TSSG TSSW 
 37783643 - 37783644 
 - 37791323 37791323 
 37791637 - - 
 - 37791783 - 
 37792822 37792821 37792821 
 37793902 - - 
 37794319 - - 
 37796841 37796840 37796840 
 37797870 37797869 37797869 
 37800289 - - 
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The FPROM program predicts more TSS and TATA box positions on Chr 22. The 
FPROM identified eight TSSs and TATA box motifs. TSSG and TSSW identified 
five TSSs and TATA box motifs. However the programs predict three of the same 
TSSs (highlighted in green) and the corresponding TATA box positions-
highlighted in blue on chromosome 22. 
 
2) The genotyping of position -571 
2.1 Detection of SNP -571 using Allele Specific Amplification 
 
The PCR allowed the SNPS to be detected in a large sample size. The PCR 
products for each allele of each SNP were run together on the same agarose gel to 
facilitate the correct genotyping of samples. Individuals homozygous for a SNP 
will yield a product in one reaction and not the other. While heterozygotes will 
yield a product of the same intensity in both reactions. The sizes of the products 
for the different alleles differ allowing accurate genotyping. A total of 165 
samples were genotyped for this SNP using ASA. 
 
 
 
Figure 11. PCR products from -571 SNP were run on a 0.7 % agarose gel. The reactions 
for each allele were done separately but run on the same gel. This gel sows the -521 G 
and -571 C reactions respectively. The -571 G reactions produces a band of size 850bp 
and the -571 C reaction produces a band of size 450 bp. Lanes 1-7 are the -571 G reaction 
of 7 samples and lanes 9-15 are the -571 C reactions of the same samples. Sample 1 and 3 
were not amplified in either reaction. Samples 2, 4, 5, and 7 are genotyped CC while 
sample 6 is genotyped GC. 
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2.2. Detection of SNP -571 using Restriction Fragment Length Polymorphism 
(RFLP) 
 
The PCR-RFLP allowed the SNP to be detected in a large sample size with 
relative ease. The gradient PCR allowed for the detection of the optimal cyclic 
conditions to amplify the ~400bp region. The annealing temperature of 58°C was 
chosen as the most favourable temperature because two of the three samples 
amplified to a better degree than at annealing temperatures of 59.3°C and 60°C. 
However, this is very subjective (Figure 13). 
 
 
The cyclic conditions are described below. 
 
 
 
 Figure 12. PCR cycling conditions for genotyping -571 SNP.  
 
 
The amplified samples were digested with MvaI and fragments run on a 4 % 
agarose gel. The assay identified 88 GG homozygotes, 35 heterozygotes and 1 CC 
homozygote. The remaining 12 genotypes were discerned from sequence data 
from 2003. Therefore there were in total 95 GG homozygotes, 39 heterozygotes 
and 2 CC homozygotes.  
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Figure 13. The gradient PCR products (400bp) for three samples 216, 340, 365 that were 
run on a 1 % agarose gel. Lanes 1, 2, 3 represent sample 216,340, & 365 at 60°C. Lanes 
5, 6, & 7 represent samples 216, 340 & 365 at 59.3°C. Lanes 9, 10 & 11 represent 
samples 216, 340, 365 at 58°C. The annealing temperature of 58°C was chosen as it gave 
the best amplification in the three samples. 
 
 
 
 
 
Figure 14 DNA fragments after restriction digestion with MvaI for 4 hours at 37 °C. 
Lanes 1 represents the uncut control DNA of size ~378 bp. Lanes 2-5 represent 
homozygotes for the G allele with fragment sizes at 215bp and 163bp. Lane 7-10 
represent heterozygotes with fragment sizes at 215bp, 163bp, 114bp and 49bp. The 49bp 
fragments are not clearly visible on the gel. No homozygotes for the C allele were 
present. 
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3. Genotype and Allele Frequencies 
 
Table 2: Genotype and allele frequencies for -571 SNPs detected by Allele 
specific amplification in subpopulation A of the whole study population and the χ2 
test 
 GENOTYPE N ALLELE ALLELE FREQ GENOTYPE 
FREQ 
χ2 
571 CC 46 C 0.41 0.279 33.363 
 CG 44 G 0.59 0.267  
 GG 75   0.455  
  165     
       
 
The sample population deviated from Hardy-Weinberg equilibrium at a p < 0.05. 
The GG homozygotes were more frequent than the CC homozygote as in below. 
The CC and CG genotypes are similar. 
 
Table 3: Genotype and allele frequencies for -571 SNPs detected by RFLP in 
subpopulation B of the whole study population and the χ2 test 
 
 GENOTYPE N ALLELE ALLELE FREQ GENOTYPE 
FREQ 
χ2 
571 CC 2 C 0.16 0.014 1.330 
 CG 39 G 0.84 0.287  
 GG 95   0.699  
  136     
       
  
The sample population did not deviate from Hardy-Weinberg equilibrium at 
p<0.05 even though the GG homozygotes were more frequent than the CC 
homozygote. The allele frequencies indicate that the G allele is more frequent in 
this subpopulation. 
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4. Detection of H186R using pyrosequencing 
 
The sequencing of a 600bp region of exon 4 showed that the sequence from 
Ensembl database was indeed correct (Figure 15).Variation was detected in 136 
samples in codon 186 within exon 4. 136 samples were sequenced using 
pyrosequencing (Figures 16).  
 
 
 
 
 
                 Figure 15. Chromatogram of sample 310 sequence. The highlighted strip shows a  
                 heterozygote for this sample at position 186. Codon 185 represented by nucleotides  
                 530, 531, 532 in the chromatogram are not polymorphic in this sample. 
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B 
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               Figure 16. Pyrogram output files for codons 186 and 185. Pyrogram A indicates the CC  
               genotype at position 186 and 185.Pyrogram B shows TT genotype was present at 186 in  
               this sample and position 185 was homozygous for C allele. Pyrogram C shows this  
               sample to be heterozygous at position 186 and homozygous for the C allele at position  
               185. 
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Table 4: Genotype and allele frequencies for H186R SNP in a subpopulation C of 
the whole study population and the χ2 test (RFLP) 
 
 GENOTYPE N ALLELE ALLELE 
FREQ 
GENOTYPE 
FREQ 
χ2 
H186R CC 4 C 0.34 0.040 11.007 
 CT 60 T 0.66 0.594  
 TT 37   0.366  
  101     
       
 
Table 5: Genotype and allele frequencies for H186R SNP in a different 
subpopulation B of the whole study population and the χ2 test (Pyrosequencing) 
 
 GENOTYPE N ALLELE ALLELE 
FREQ 
GENOTYPE 
FREQ 
χ2 
H186R CC 24 C 0.49 0.176 7.102 
 CT 86 T 0.51 0.632  
 TT 26   0.191  
  136     
 
The H186R SNP does deviate from the Hardy-Weinberg Equilibrium at p < 0.05. 
The genotypes are representative of those on the antisense strand. There is a large 
heterozygote excess and almost equal proportion of either homozygote.  
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5. Association of APOBEC3G genotypes with HIV/AIDS disease status 
 
   Table 6. Genotypes in the General population and HIV positive sub grouping  
 
  
General population 
 
HIV + 
Upstream 
non 
coding 
region 
Genotype n Freq χ2 P n Freq χ2 P 
- 571 CC 
CG 
GG 
0 
3 
29 
32 
0 
0.094 
0.906 
0.369 0.5 2 
37 
65 
104 
0.019 
0.356 
0.625 
3.603 0.05 
H186R CC 
CT 
TT 
3 
19 
10 
32 
0.094 
0.594 
0.313 
11.224 0.001 21 
67 
16 
104 
0.202 
0.644 
0.154 
8.477 0.01 
 
The HIV positive and the General population did not deviate from Hardy 
Weinberg Equilibrium at P<0.05 at -571 locus. The GG genotype is frequent in 
both sub groups. There is an absence of the CC genotypes in the general 
population and a very low frequency in the HIV positive group. There is a 
significant difference at H186R locus. There is a large heterozygous excess in 
general population and HIV positive groups. In the general population the TT 
genotype is more frequent than the CC genotype. However, in the HIV positive 
group the CC genotype has a higher frequency than the TT genotype.  
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6. Chi-squared Test: 2x 2 table 
 
Table 7. Independent Chi-squared test for frequency distributions between the 
General population and HIV positive group for SNPs -571 and H186R 
 
SNP Chi squared value P-value 
-571 GP/HIV pos 9.068 0.0026 
H186R GP/HIV pos 5.059 0.0245 
 
Chi-squared test using the co-dominant model was conducted to compare 
frequencies between the General population and HIV + populations at H186R. 
There was a significant difference in frequencies between the two groups. This is 
suggestive of them playing a role in HIV/AIDS pathogenesis. 
 
7. Pair-wise Allelic Linkage Disequilibrium 
 
Table 8 Linkage disequilibrium in APOBEC3G gene 
 
Site D |D’| r2 
-571/ H186R -0.127 0.216 0.0087 
 
Pair-wise Linkage disequilibrium analysis across the two SNPs showed that they 
are not in linkage disequilibrium because the  D‟| value for this association was 
less than 0.46 (Kidd et al, 1988). There is no correlation between the alleles at the 
two loci because the r
2 
is very low. 
 
8. Haplotype analysis 
 
The haplotypes across upstream non coding SNP and coding region SNP were 
analyzed using PHASE 2.0. 
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Table 9. Haplotype frequencies for the sample population. 
Haplotype Name  Haplotype Frequency 
1 GC 0.418 
2 GT 0.419 
3 CC 0.074 
4 CT 0.087 
 
There are four haplotypes present in this study population. Haplotype 1 and 2 
have equal frequencies while Haplotype 3 and 4 and comparable at 0.074 and 
0.084 respectively. 
 
Table 10. Haplotype analysis in General population and HIV positive subgroups 
 
Haplotype Haplotype Frequency in HIV 
positive pop. (104) 
Frequency in General 
pop. (32) 
1 GC 0.431 0.368 
2 GT 0.371 0.585 
3 CT 0.104 0.024 
4 CC 0.092 0.022 
 
The GC haplotype was more common in the HIV positive population while the 
GT haplotype had a higher frequency in the general population (Table 7). The 
least common haplotype in both groups was haplotype 4. It occurred at a low 
frequency of 0.092 and 0.022 in the HIV positive and the general population 
respectively. The frequency of haplotype 1 was comparable between the two 
groups. However the remaining haplotypes were dissimilar between the groups. 
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DISCUSSION 
 
Analysis of the direct sequencing of the upstream non-coding region showed six 
polymorphisms in 20 samples. SNP -90 was characterised only in six samples. 
SNPs -163, -166 and -199 appear to be in linkage disequilibrium. All three sites 
are either heterozygous or homozygous for the major alleles at each position. SNP 
-571 was well represented in the sequenced samples. Promoter analysis identified 
numerous transcription start sites (TSS) as well as several TATA box motifs 
(TBM). The FPROM programs identified eight TSSs and eight TBMs. The 
remaining two identified five promoter elements and five TBMs, four of which 
are identical. FPROM only identified three of those detected by TSSG and TSSW. 
FPROM seemed less stringent in promoter identification than TSSG and TSSW. 
The -571 SNP was genotyped with Allele Specific amplification (ASA) and RFLP 
analysis. While the H186R was genotyped with RFLP analysis and 
pyrosequencing. Genotyping of the study population at -571 and H186R showed 
that these SNPs deviated from Hardy Weinberg equilibrium (HWE). However, 
when the -571 study population was genotyped with RFLP analysis the population 
did not show any significant deviation from HWE. A large heterozygotes excess 
was found at the H186R locus. The difference in genotype frequency distributions 
between the HIV + and general populations at -571 and H186R was significant. 
The GT haplotype was more prevalent in the whole study population. However it 
was not the most frequent in the HIV+ group. 
 
Direct sequencing remains the unsurpassed method for detecting variation. 
However it is relatively expensive so in the context of this study it was used an 
exploratory tool. There after indirect genotyping assays were designed to 
genotype the study population. Allele specific amplification did allow the 
genotyping of the study population at -571. However, in this study the ASA 
erroneously genotyped some samples when compared to the RFLP analysis. In 
ASA homozygotes were represented by a single band in either reaction while 
heterozygotes are represented by two bands of equal intensity. Certain samples  
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amplified with two bands but of very unequal intensity, a very bright band and a 
very dim band. Thus one has to use discretion when genotyping these samples by 
this method. The deviation from Hardy Weinberg is the result of the incorrect 
genotyping, which is the result of the assay not being specific enough to detect the 
variants correctly. The RFLP analysis was a more reliable technique. The 
discriminatory power is great because it allows one to design the assay at a 
species level or population level as in our study. The uncut control in the RFLP 
analysis ensured the assay was working correctly. In addition, the sequence data 
allowed the assay to be tested with control samples where the genotype was 
known. The drawback of using this technique is that a large amount DNA is 
required. This can be overcome by an initial PCR amplification as in this study. 
Thus, this method was more reliable in genotyping. Consequently, genotyping by 
RFLP analysis the study population did not deviate from the HWE. Similarly, 
pyrosequencing is a reliable technique because it is based on sequencing. 
However, it does require a lot of technical work to get the assay working. Once 
the assay is optimized a large number of samples can be genotyped at once.  
 
The promoter analysis identified promoters. However, they were not the same as 
those identified in a previous study (Muckenfuss et al, 2007). The first TSS 
located with the FPROM program was 2748 bp upstream of the transcription 
initiation start site. All other promoters identified were between 2798 bp and 
17208 bp upstream of the start site of the APOBEC3G mRNA. In contrast a TSS 
was located 66 nucleotides upstream of the start of the mRNA sequence 
(Muckenfuss et al, 2007).The core promoter of APOBEC3G was located within 
the region -114 and +66 (Muckenfuss et al, 2007). These positions correspond to 
37802858 and 37803081 on chromosome 22 respectively, and were not identified 
with the promoter software programs. In addition the GC box was mapped to -87/ 
-78 (37802929/ 37802938) of the promoter region. This box was not identified by 
the software analysis. No independent studies have confirmed the results obtained 
by Muckenfuss et al (2007) but these results seem promising when compared  
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against what has been written about the features of promoters in the literature. 
Promoters in general have a TATA box located 10 nucleotides upstream of the 
TSS, followed by an element at 25 nucleotides upstream of the TSS and finally a 
CAAT element at 80 nucleotides upstream of TSS. Although APOBEC3G does 
not the typical elements at -10 and -25 it does appear to have the CAAT element 
present encompassing the same region (Klugg & Cummings, 1997). 
 
Comparison of the genotyping results with the literature shows some marked 
differences. This study‟s frequencies were compared to the Yoruba population 
from Nigeria and African Americans. The Yoruban and African American data 
was obtained from dbSNP and Ensembl. 
 
Table. 11. Comparison of population frequencies across three populations groups 
 -571 H186R 
 Genotyp
e 
Genotype 
Frequenc
y 
Allele 
Frequenc
y 
Genotyp
e 
Genotype  
Frequenc
y 
Allele 
Frequenc
y 
This 
study 
CC 
0.279 C= 0.I6 
CC 
0.176 C=0.41 
 CG 
0.267  
CT 
0.632  
 GG 
0.455 
G= 0.84 TT 
0.191 
 T=0.59 
 
Yoruban CC 0.850 C=0.917 CC 0.217 C=0.467 
 CG 0.133  CT 0.533  
 GG 0.017 G=0.083 TT 0.283 T=0.550 
 
African 
America
n 
X X X CC X C=0.390 
 X X X CT X  
 X X X TT X T=0.610 
       
*The frequency data for the Yoruban and African Americans was obtained from dbSNP and Ensembl respectively. 
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The -571 allele frequencies are similar between the Yoruban and this study 
however, the genotype frequencies between the two are very different. The GG 
genotype has a higher frequency in this study but has a very low frequency in the 
Yoruba. The CC genotype was considerably higher in the Yoruban than in this 
study. There was no data available for African Americans thus no conclusions can 
be drawn regarding the similarities and/or differences in frequencies between AA 
and the Bantu population. Nonetheless, African has 2000 ethnically diverse 
populations. This difference in frequencies shows that the Yoruban population, 
from Nigeria, is different from the Bantu speaking study population. These ethnic 
differences do affect the genotype frequencies. The genotype frequencies for 
H186R are different between this study and the Yoruban. However, there remains 
a heterozygote excess in both populations. The TT genotype has a frequency of 33 
% in African Americans (An et al, 2004). In contract TT genotype within this 
study population was 20 %. CC and TT genotype frequencies are analogous 
within both populations. In contrast the allele frequencies in the Yoruban 
population are equivalent to those in this study. However they appear to differ 
from the allele frequencies of African Americans (AA). No genotype data was 
obtained for AA at H186R and it would be interesting to note if there is still a 
heterozygote excess in this population group. This heterozygotes excess is not 
present in the CEPH (Utah residents with ancestry, from Northern and Western 
Europe), the Han Chinese and the Japanese populations studied in the HapMap. 
The frequency of the TT genotype for the CEPH, Han Chinese, and Japanese are 
0.933, 0.911, and 0.822 respectively. This indicates that selection must be 
operating with this study population and the Yoruban allowing fro the 
heterozygote excess. 
 
The heterozygote excess at H186R could be indicative of incorrect genotyping. 
However, two reliable methods employed showed similar results, suggesting that 
that this is not a result of incorrect genotyping. The TT genotype was more 
frequent in the general population than in the HIV+ group. This is expected  
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because more people would be advancing to AIDS and death hence less of this 
genotype would be found within an HIV + population. This consistent with a 
previous study where the TT genotype is associated with faster progression to 
progression AIDS (An et al, 2004). The substitution of histidine (H186) to 
arginine (186R) results in a change of charge from negative to positive. This 
change in polarity may influence the structure of APOBEC3G binding to vif thus 
leading to faster progression to AIDS. There also seems to be selection against the 
GG genotype at -571 in the HIV + group and thereby increasing the frequency of 
the CC and CG genotypes. The GG genotype of -571 is more frequent in the 
general population than in the HIV + group. Likewise, as more individuals 
progress to AIDS and death the GG genotype is reduced. Therefore, there is 
selection against this genotype in HIV + group. There is no reported clinical 
implication associated with the GG genotype at -571. The p-values indicate that 
the frequency distributions at -571 (0.0026) and H186R (0.0245) are statistically 
significant. To know for certain the impact of these SNPs on Bantu speaking 
population a well characterised sample needs to be studied. This means that a 
cohort of HIV -, HIV + and high risk exposed uninfected (HREU) individuals 
need to be followed over a period of time. In addition reported clinical details of 
the HIV+ group needs to be noted such as date of initial infection, CD 4 counts, 
and other illnesses such as TB. HIV status for the general population sampled in 
this study is unknown. This population was initially used to detect variation and 
may not be suitable to study disease susceptibility and progression. In addition, no 
reported clinical details were obtained for the HIV + group. Thus, the samples to 
be investigated need to be well characterised. 
 
The pair wise allelic Linkage Disequilibrium of -571 and H186R showed that they 
are not in Linkage Disequilibrium, |D‟| is 0.216. In contrast they appear to be 
linked in AA and the |D‟| is 0.967 (An et al, 2004). This lack of correlation is 
interesting because these SNPs are relatively close together on the chromosome 
and the literature suggests that SNPs within 10kb are always in strong Linkage  
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Disequilibrium (Goldstein & Weale, 2001). In addition, linkage studies on 
Yoruban population indicates the |D‟| drops below 0.5 on average every ~5kb. 
The -571 and H186R SNPs are just over 5000bp apart. However it is known that 
Africans have weak Linkage Disequilibrium based on studies of the Yoruban 
population (Reich et al, 2001). So the lack of linkage in this Bantu-speaking 
population is not surprising considering that this population may have a lower LD 
and therefore much more variant alleles.  
 
An alternative explanation for the heterozygotes excess is copy number variations 
(CNVs). APOBEC3G gene has 8 exons. Exons 2, 3, 4 are duplicated within 5, 6, 7 
resulting in two active site (2, 5), two linker regions (3, 6) and two 
psuedocatalytic domains (4, 7). This architecture has the potential for CNVs. 
CNVs have been reported to occur in regions within large homologous regions 
such as these duplicated exons (Freeman et al, 2009). In addition these 
duplications can be maintained by non homology based mechanisms leading to 
grater chromosomal re-arrangements within the gene. A consequence of CNVs is 
are allele frequencies that deviated form the expected Hardy-Weinberg 
equilibrium such as the heterozygotes excess of H186R SNP obtained through 
RFLP analysis and confirmed via pyrosequencing. However the Bantu speakers 
from South Africa have comparable number of CNV per loci pee individual when 
compared to the rest of the world (Jakobsson et al, 2008). This approach needs 
further investigation with well characterised individuals to ascertain the 
contribution of CNVs to disease especially HIV. 
 
APOBEC3G remains a promising target in the study of HIV/AIDS pathogenesis. 
Functional studies need to be conducted to ascertain the exact contribution of this 
gene in HIV/AIDS. Future studies include expression analysis on well 
characterised samples. A good example of expression analysis to use in future 
studies is siRNA analysis directed against APOBEC3G. This will show the 
efficiency of APOBEC3G proteins on retroviral infection in a South African  
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context where HIV-1 type C is the most prevalent subtype. To determine with 
accuracy if this gene is involved in susceptibility to HIV and progression to AIDS 
well characterised subjects need to be followed over time. These samples were 
very hard to acquire in Johannesburg. Nonetheless, this study proves that 
APOBEC3G plays a pivotal role in disease. 
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CONCLUSION 
 
The study succeeded in genotyping the study participants at -571 and H186R. The 
frequency distributions of the SNPs between the HIV+ and the general population 
were statistically significant indicating that -571 and H186R variants do have a 
modifying role on HIV/AIDS pathogenesis. In particular these variants seem to be 
under selective pressure. Interestingly these variants though in close proximity are 
not linked and this warrants further investigation with better characterised 
samples. The differences in allele, genotype and haplotype frequencies seem to be 
in part population-specific. This is consistent with literature which indicates that 
Bantu speaking populations have been shaped by different selection pressures 
compared to Europeans and African Americans. 
 
The only way to facilitate the proper Linkage Disequilibrium and Haplotype 
analysis is to have a more extensive reference panel. This panel must encompass 
populations from Southern Africa including the Bantu-speaking population. This 
will ensure better a more relevant predication of LD and consequently the 
haplotype inference will be more meaningful. 
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APPENDIX 
Raw Data Subpopulation A 
Sample 571-ASA Sample 571-ASA Sample 571-ASA Sample 571-ASA 
104 CC 171 CC 219 GC 541-353 GG 
105 CC 172 CC 220 GC 541-36 GG 
106 CC 173 CC 221 GC 541-49 GG 
109 CC 175 GC 222 GC 541-62 GG 
110 CC 176 GC 223 GG 541-73 GG 
111 CC 177 GC 224 GG 541-98 GG 
112 CC 178 GC 225 GG 614-121 GG 
113 CC 179 GC 227 GG 615-107 GG 
114 CC 180 GC 228 GG 615-11 GG 
115 CC 181 GC 229 GG 615-136 GG 
116 CC 182 GC 230 GG 615-15 GG 
117 CC 183 GC 231 GG 615-26 GG 
118 CC 184 GC 232 GG 615-31 GG 
120 CC 185 GC 233 GG 615-325 GG 
123 CC 187 GC 234 GG 615-332 GG 
124 CC 188 GC 235 GG 615-340 GG 
126 CC 189 GC 236 GG 615-358 GG 
127 CC 190 GC 237 GG 615-377 GG 
131 CC 191 GC 239 GG 615-394 GG 
138 CC 192 GC 241 GG 615-406 GG 
140 CC 193 GC 243 GG 615-59 GG 
141 CC 194 GC 244 GG 615-67 GG 
143 CC 195 GC 245 GG 615-78 GG 
146 CC 197 GC 521-160 GG 615-80 GG 
147 CC 198 GC 521-171 GG 615-93 GG 
148 CC 199 GC 521-298 GG 616-17 GG 
149 CC 200 GC 521-301 GG 616-42 GG 
150 CC 201 GC 521-327 GG 616-445 GG 
151 CC 203 GC 521-343 GG 616-453 GG 
152 CC 204 GC 536-015 GG 616-457 GG 
153 CC 205 GC 536-107 GG 616-472 GG 
154 CC 206 GC 536-149 GG 616-486 GG 
155 CC 207 GC 536-173 GG 616-499 GG 
156 CC 208 GC 536-31 GG 616-503 GG 
158 CC 209 GC 541-115 GG 616-91 GG 
159 CC 210 GC 541-131 GG 615-366 GG 
160 CC 211 GC 541-144 GG   
161 CC 212 GC 541-178 GG   
163 CC 213 GC 541-180 GG   
164 CC 214 GC 541-193 GG   
167 CC 216 GC 541-228 GG   
168 CC 217 GC 541-234 GG   
170 CC 218 GC 541-256 GG   
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Raw Data Subpopulation B 
Sample 
H186R-
Pyro 
571- 
RFLP Sample 
H186R-
Pyro 
571- 
RFLP Sample 
H186R-
Pyro 
571- 
RFLP 
101 CT GC 243 CC GC 341 CT GC 
105 CT GG 245 CT GG 342 CC GG 
106 CT GC 300 CT GG 343 TT GG 
111 CC GG 301 CC GG 344 CT GC 
113 TT GG 302 CC GG 346 CT GG 
114 TT CC 303 CC GC 347 TT GC 
118 CC GC 304 CC GC 348 CT GC 
119 CC GG 305 CC GC 349 TT CC 
126 CC GG 306 CT GG 356 CT GC 
127 TT GC 307 CC GG 357 CT GG 
131 CT GG 308 CC GG 358 CT GG 
141 CT GC 309 CT GG 360 TT GG 
142 CT GG 310 CT GG 361 TT GG 
206 TT GG 311 CT GG 362 CT GG 
208 TT GG 312 CT GC 363 CT GG 
209 CT GG 313 CT GG 365 CT GG 
210 CT GG 314 TT GC 366 CT GG 
212 TT GG 315 TT GG 367 CT GG 
213 CT GG 316 CT GG 368 CT GG 
214 CT GG 317 CC GG 369 CC GG 
215 CT GG 318 CT GG 370 CC GG 
216 CT GG 319 CT GG 371 TT GG 
217 CT GG 320 CT GG 372 CT GC 
221 CT GG 321 CT GG 373 CT GC 
222 CT GG 322 CT GG 374 TT GC 
223 TT GG 323 CT GG 375 CT GC 
224 TT GG 324 CT GC 376 CT GC 
226 CT GG 325 CT GC 377 CT GC 
227 CT GC 326 CT GC 378 CT GG 
228 CT GG 327 CC GC 379 CT GG 
229 CT GG 328 CT GC 381 CT GG 
230 CT GG 329 CT GC 382 CT GG 
231 CT GG 330 CT GC 383 CT GC 
232 CT GG 331 CT GC 384 CT GG 
233 CC GG 332 CC GC 385 CT GG 
234 CT GG 333 CT GC 386 CT GG 
235 TT GG 334 CT GC 387 TT GG 
237 CT GG 335 CC GC 390 CT GG 
238 TT GG 336 CT GC 391 CC GG 
239 CC GG 337 CT GC 392 CT GG 
240 TT GG 338 CT GC 393 TT GG 
241 TT GG 339 CT GG 394 CT GG 
242 TT GC 340 TT GG 395 CT GG 
396 CC GG 397 CC GG 398 CT GG 
399 TT GG 400 CT GG 401 CT GG 
402 CT GG       
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Raw Data Subpopulation C 
Sample H186R Sample H186R Sample H186R 
105 AA 213 AG 541-62 AG 
109 AA 214 AG 541-73 AG 
111 AA 215 AG 541-85 AG 
112 AA 216 AG 541-131 AG 
113 AA 217 AG 541-144 AG 
126 AA 218 AG 541-242 AG 
147 AA 221 AG 541-256 AG 
150 AA 222 AG 541-353 AG 
151 AA 223 AG 615-11 AG 
152 AA 224 AG 615-26 AG 
153 AA 225 AG 615-31 AG 
154 AA 226 AG 615-44 AG 
155 AA 227 AG 615-59 AG 
156 AA 229 AG 615-67 AG 
160 AA 230 AG 615-78 AG 
161 AA 231 AG 615-93 AG 
172 AA 232 AG 615-107 AG 
175 AA 233 AG 615-136 AG 
176 AA 234 AG 615-325 AG 
181 AA 235 AG 615-332 AG 
182 AA 236 AG 616-17 AG 
183 AA 237 AG 616-42 AG 
184 AA 238 AG 616-91 GG 
188 AA 239 AG 616-445 GG 
189 AA 240 AG 616-457 GG 
190 AA 241 AG   
193 AA 242 AG   
194 AA 243 AG   
195 AA 244 AG   
197 AA 245 AG   
198 AA 521-171 AG   
199 AA 521-298 AG   
200 AA 521-301 AG   
201 AA 521-316 AG   
203 AA 521-327 AG   
204 AA 521-343 AG   
205 AA 536-015 AG   
220 AA 536-31 AG   
206 AA 536-107 AG   
208 AA 536-149 AG   
209 AA 536-173 AG   
211 AA 541-36 AG   
212 AG 541-49 AG   
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